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Summary 
Alginate microcapsules have the potential as immune barriers for cell transplantation where 
the alginate gel protects the transplant from the host immune system. Microencapsulation can 
thus provide a way to overcome the need for immunosuppressive drugs. The successful use of 
alginates as immobilization material has, however, been hampered by their mechanical 
instability and high porosity. To overcome this problem, a polycation layer has traditionally 
been added to the alginate gels. However, polycations are toxic to cells and provoke 
inflammatory reactions. Hence, the main goal of the present work was to improve the 
functionality of alginate gels in order to omit the use of polycations. Alginate gel properties 
were found to depend strongly on many factors such as the choice of alginate material, choice 
of gelling ion and method of preparation, all which can be manipulated to form alginate gel 
beads with enhanced functionality.   
In particular, specific enzymes (C-5 epimerases) that modify the alginate chain were used to 
form novel alginate materials, some with extreme composition not found in nature. Gels of 
enzymatically engineered alginate were found to be more elastic and compact, less permeable, 
and extremely stable under physiological conditions, offering significant advantages over 
native alginates. Hence, by controlling alginate nanostructure in a highly specific way, we 
were able to manipulate the macroscopic properties.  
One of the most striking features of epimerization was the effect seen upon increasing the 
amount of alternating sequences in the alginate chains using the specific epimerase AlgE4. On 
the basis of a detailed study on the resulting products of AlgE4 epimerized alginate we 
hypothesized the direct involvement of the alternating sequences in junction formation. 
The choice of gelling ions for alginate gel formation was also found to have significant effects 
on the final gel properties. Interestingly, the effect was highly dependent on the alginate 
material used. Application of alginates with extreme composition revealed that different block 
structures in the alginate bound the ions to different extent. Alginate beads with enhanced 
functionality could hence be formed using a proper combination of ions and alginate material.   
Finally, confocal laser scanning microscopy (CLSM) was established as a versatile and easy 
method to visualize the macroscopic character of alginate microcapsules such as the polymer 
distribution in capsules. Further, effect of different encapsulation procedures on the final 
capsule characteristics was revealed.   
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1 INTRODUCTION 
1.1  Motivation 
Entrapment of living cells or other biologically active compounds is a well established 
method both for effective protection of the immobilized material and administration of low 
molecular weight compounds like drugs, proteins, food additives and chemicals. Although the 
potential uses of these systems in medicine, food industry and agriculture are numerous, much 
focus has been on the encapsulation of living cells for transplantation purposes. The far most 
studied system is the encapsulation of insulin producing cells (islets of Langerhans) into 
calcium-alginate microcapsules for transplantation into diabetic patients as an approach to 
treat Type 1 diabetes. The capsule acts to protect the transplanted cells from the host immune 
system by physical isolation of the graft. 
In spite of extensive research in the field, there are still many problems connected to the use 
of alginate microcapsules as an immune barrier for transplantation purposes. One of the major 
obstacles preventing the use of alginate capsules in vivo has been overgrowth of immune cells 
on the capsule surface, which can cause failure of encapsulated cells. Cellular overgrowth has 
been attributed to an immune response to foreign cellular material leaking out through the 
capsule membrane, direct exposure of cells through capsule breakage or to the capsule 
material itself. Under physiological conditions the capsules are also exposed to a combination 
of destabilizing forces, leading to swelling, increased pore size, dissolution, and capsule 
rupture. To protect the cells from the host immune system, the capsule must therefore be 
carefully designed, especially with respect to stability and porosity. Traditionally, an outer 
polycation layer has been added to the capsules in order to decrease porosity and increase the 
long-term stability of alginate gel beads. Several studies have, however, indicated that the 
polycation provokes inflammatory reactions. Hence, one of the main goals and challenges of 
the present work has been to make alginate gel beads that are stable under physiological 
conditions over extended periods of time, without the use of polycations. The hope is that the 
great - and still growing - knowledge about alginate structure-function relationships can be 
used for this purpose. 
With the high interest and expectations connected with the use of immobilized islets as 
treatment for Type 1 diabetes, the largest motivation for the present work has been to design 
an alginate bead for this specific application. However, upon learning more about these 
relations, other existing alginate technologies and new applications may be implemented.  
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1.2 Immunoisolation  
Transplantation of living cells is a potential strategy for treatment of various diseases caused 
by the body’s inability to produce required amounts of an essential molecule such as a 
hormone or an enzyme. Such cell therapy treatment involves the replacement or repair of 
damaged tissue or cells by means of transplantation of human or animal cells. As for whole 
organ transplants, patients undergoing cell therapy treatments run the risk of rejection, in 
which the body recognizes the cells as a foreign substance and seeks to destroy the transplant. 
As a consequence, a lifelong need for immunosuppressive drugs is required with the 
concomitant increased risk of tumor development [1], frequent infections and general toxicity 
[2]. In fact, the side-effects can be so severe that the disadvantages of such drugs outweigh the 
benefit of the transplant.  
The general concept of immunoisolation is to prevent rejection by separating the transplanted 
cells from the hostile immunological environment in the host by a selectively permeable 
artificial membrane. The small pores of the membrane prevent the passage of high-molecular 
weight substances such as large antibodies and cytotoxic immune cells, at the same time 
allowing free passage of smaller molecules like nutrients, electrolytes, oxygen and 
biotherapeutic agents [3, 4] (Figure 1).  
 
 
 
Figure 1. Immunoisolation exemplified by encapsulated therapeutic cells for transplantation purposes. 
The capsule material is typically a hydrogel matrix. Adapted and modified from [4].  
 
Capsule
Therapeutic cells
Cell products 
(e.g insulin)
Nutrients and oxygen
Host immune system
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Immunoisolation hence allows for transplantation of cells without the need for permanent 
immunosuppression. In addition, it may offer the possibility for successful transplantation of 
non-human tissue (xenotransplantation) in order to overcome the shortage of human organs 
[3, 5, 6]. The use of immunoisolation to transplant cells and tissues offers the opportunity to 
revolutionize current therapy for a wide variety of human diseases [5, 7-10] including the 
treatment of Parkinson’s disease [11], liver failure [12], glioblastomas [13-15], hypocalcemia 
[16, 17], dwarfism [9] and diabetes mellitus [18].  
 
Apart from immunoisolation, other major methods to avoid immunological responses include 
the use of immunosuppressive drugs, induction of tolerance to donor tissue in the host [19] or 
pretreatment of the graft to reduce immunogenicity [10, 20]. 
 
1.2.1 Host reactions to transplanted cells 
Transplanted cells are naturally recognized as foreign material by the host immune system 
which as a result will seek to destroy the graft in a highly sophisticated manner. Immune 
rejection is the most important host response towards the cellular component being an 
allograft (same species) or xenograft (unlike species). The immune reaction against an 
allograft or a xenograft is complex and involves cells, antibodies, complement and cytokines 
which can cause cell damage. To understand how encapsulation may protect transplanted cells 
against these damaging components of the immune system, a brief presentation of the main 
host defense mechanisms are given below. These mechanisms can be divided in cellular and 
humoral immune responses. Figure 2 summarizes the challenges of an immunoprotective 
barrier.  
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Figure 2. Simplified illustration of the challenges of an immunoisolating device. Adapted and modified 
from [21]. 
 
The cellular responses involve recognition of Class I major histocompatibility complex 
(MHC) on the donor graft by receptors on CD4+ or CD8+ T cells (direct pathway) leading to 
cytolytic killing of the donor cells. Immunoisolation of the graft can prevent the direct contact 
between grafted cells and T-cells, thus preventing the cytotoxicity. The direct pathway plays a 
dominant role in acute or early allograft rejection and may be less important in xenograft 
rejection which largely provokes the indirect pathway. 
The indirect pathway involves recognition of antigens on the donor cell surface by antigen 
presenting cells (macrophages, B-cells, monocytes, dendritic cells) in association with Class 
II MHC molecules. The antigens are presented by these cells to the host CD4+ cells which 
secrete cytokines to provide necessary signals for growth, maturation and activation of 
cytotoxic CD8+ cells, B-cells, macrophages, leukocytes and endothelial cells. Although 
cytokines primarily act as a signaling system between immune cells, they are also capable of 
killing cells directly. Examples include interleukin-1β (IL-1β), tissue necrosis factor-α (TNF-
α) and interferon-γ (IFN-γ). Various components leaking out from transplanted cells through 
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the artificial membrane (secreted proteins, cell surface antigens, phospholipids or DNA from 
dead cells) can act as antigens and thus initiate the indirect pathway.  
 
While an immune barrier may prevent the direct contact between host and donor cells, the 
ingress of components of the humoral response may be a tougher challenge to meet. This 
involves production of naturally occurring antibodies against the graft (IgG, IgM) and 
complement activation. Binding of an antibody to the donor cell surface will normally not 
cause any damage. The cytotoxic events begin only if complement components pass through 
the membrane. Binding of the first complement component to IgM or IgG initiates a cascade 
ending in cell lysis [21, 22].  
 
In addition to the cellular and humoral responses, macrophages and certain other immune 
cells can secrete low molecular weight reactive metabolites of oxygen and nitrogen including 
free radicals and nitric oxide which are toxic to cells in an nonspecific manner [21, 23]. As 
these components are smaller than the crucial nutrients and cell products that need to be able 
to diffuse freely through the immune barrier, their ingress cannot be prevented. However, 
although toxic to cells, their lifetime is short meaning that the damage they can cause will 
depend on how far they can diffuse before they disappear as a result of chemical reactions 
[21]. 
 
1.2.2 Immunoisolation devices 
A large variety of immobilization devices of different geometries have been proposed for cell 
transplantation purposes. The primary encapsulation devices can be categorized by 
intravascular macrodevices, extravascular macrodevices and microcapsules (Figure 3) [3, 6, 
22, 24-27].  
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Figure 3. Immunoisolation devices. ↕ indicates transport of molecules over the immunoisolating 
membrane. Adapted and modified from [24].  
 
Macrodevices are characterized by their large size (0.5-1.5 mm inner diameter, 1-10 cm in 
length) and internal capacity, containing thousands to millions of cells. The most common 
geometric configurations are intravascular chambers, hollow fibers and flat membranes 
(sheets) of different geometries. The intravascular macrodevices (chambers) are connected 
directly to the host’s circulatory system. The blood flows through a microporous tube with a 
housing on the outside containing the implanted tissue [6, 25]. The graft is thus in close 
vicinity to the blood, allowing the graft to be well nourished. However, the risks connected 
with major surgery for implantation and retrieval as well as blood clotting has resulted in the 
lack of interest for this device over the last years [3, 24]. Extravascular devices are usually 
transplanted into the peritoneal cavity or subcutaneously and rely on the formation of new 
blood vessels. The major disadvantages of macrodevices have been their short life time due to 
breakage and fibrosis and the small surface to volume ratio. An advantage of these devices is 
the easiness of retrieval [24, 25].  
Microencapsulation involves immobilizing cells in small spherical capsules or beads (0.2-1.0 
mm in diameter). Most applications require thousands to hundreds of thousands of beads to 
provide the necessary cell number for a therapeutic dose. Microcapsules offer several distinct 
advantages over the use of macrocapsules, including greater surface to volume ratio, ease in 
manufacturing and a wider range of transplantation sites. In addition, implantation of 
microcapsules is usually by injection which removes the need for invasive surgery. 
Microcapsules are typically more durable than macrocapsules and more difficult to disrupt. 
Vein
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As only a few cells are encapsulated in each microcapsule, the whole graft is not lost if one 
capsule should brake. However, a disadvantage with the use of microcapsules can be the 
difficulty of retrieval if required, which typically is performed by lavage and needle aspiration 
[3, 24, 27]. To date, the limitation with the use of microcapsules has been fibrotic overgrowth 
and low stability. 
 
1.2.3 Microcapsule materials  
Finding a suitable material to construct an immunoisolating device is challenging: The 
capsule must be sufficiently permeable to allow nutrients to enter and therapeutic proteins to 
escape and it must be stable over extended time periods. In addition, the material must be 
non-toxic, cell-compatible and biocompatible. Ease of processing, sterilizability and mild 
encapsulation conditions are also of importance [25]. 
Numerous materials, both natural and synthetic, have been proposed for cell encapsulation 
including poly(glycolic acid) (PGA) [28], poly(lactic-co-glycolic acid) (PLGA) [29], agarose 
[30, 31], polyacrylates [25, 32], κ-carrageenan [33] and alginate [34]. Coating of cells with 
heparin [35], poly(ethylene glycol) (PEG) [28, 36], or various polycation nanolayers [37] has 
also been suggested. In addition, several combinations of materials forming multicomponent 
capsules have been proposed [30, 38] allowing independent control of different capsule 
parameters.  
Due to their high water content and three-dimensional matrix structure thereby stabilizing 
biologically active substances, hydrogels of naturally occurring or synthetic polymers are the 
most commonly used materials for microencapsulation. Their hydrophilic nature reduces the 
friction between the capsule and surrounding fluids and tissues. In addition, hydrogels have a 
pliable consistency which prevents damage to surrounding tissues. Although some water-
insoluble materials, due to their high stability, have been preferred by some groups for 
encapsulation of living cells, these are often limited by the need for organic solvents which 
may influence cell viability. Transparent hydrogels also allow easy visualization of the 
encapsulated cells [6, 25, 26]. 
Of all hydrogels used for microencapsulation, alginate has been and will be one of the most 
important immobilization materials [39, 40]. In addition to being heat stable, alginates possess 
the ability to form hydrogels rapidly and under very mild (physiological) conditions [41]. 
Moreover, no alginate-degrading enzymes have so far been reported in humans. Combined 
INTRODUCTION 
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with the fact that alginates are highly characterized and well understood both in the liquid and 
gel phase makes this biopolymer unique as an immobilization material.  
 
1.3 Alginate  
1.3.1 Source and applications 
Alginate, first described by Stanford in 1881 [42], is a polysaccharide mainly occurring as a 
structural component in marine brown algae (Phaeophyta) [43]. A polymeric material 
resembling alginates from brown algae is, however, produced as a capsular component in soil 
bacteria such as Azotobacter vinelandii [44] and several species of Pseudomonas [45, 46]. In 
particular, the alginate-secreting bacterium Pseudomonas aeruginosa in cystic fibrosis 
patients [47] has gained much focus in recent years. In brown algae, alginate is the most 
abundant polysaccharide comprising up to 40% of the dry matter [48], mainly occurring in the 
cell walls and intercellular spaces where it consists of an insoluble mix of calcium, 
magnesium, sodium, and potassium salts [49]. Its main function is to contribute to the 
strength and flexibility of the seaweed plant, and the composition of the alginate varies both 
within different species of algae and within different parts of the plant [50]. Industrially, 
alginate has for many decades been used for its gelling, viscosifying and stabilizing properties 
and for its ability to retain water [51]. Alginates also have recognized potential in removal of 
toxic heavy metals from industrial waste by biosorption [52]. More recently, new 
biotechnological, biomedical and pharmaceutical applications have been added to the list, and 
some new alginate based materials have also emerged from extensive research in the field [4, 
53].  
 
Although present research holds many promises to the possibility of alginate production by 
microbial fermentation and post-polymerization modification of the molecule, all 
commercially available alginates are at present extracted from algae [4, 48]. The annual 
industrial production of alginate is about 30,000 metric tons. However, the sources of alginate 
may be regarded as unlimited [48].   
 
INTRODUCTION 
 9
1.3.2 Composition, sequence and molecular weight 
Alginate is a family of linear binary copolymers of (1→4) glycosidically linked α-L-guluronic 
acid (G) and its C-5 epimere, the β-D-mannuronic acid (M) residue [54] (Figure 4a). The 
relative amount of the two uronic acid monomers as well as their sequential arrangement 
along the polymer chain differs widely, depending on the origin of the alginate. The uronic 
acid residues are distributed along the polymer chain in a pattern of blocks, where 
homopolymeric blocks of G residues (G-blocks), homopolymeric blocks of M residues (M-
blocks) and blocks with alternating sequence of M and G units (MG-blocks) co-exist (Figure 
4b) [55]. In M-blocks, diequatorial linkages connect the mannuronate residues forming a flat 
ribbon-like structure whereas in G-blocks, the linkage between two guluronate units is diaxial 
and hence shorter. G-blocks are therefore more buckled and less flexible, with junctions 
between the residues stabilized by intra-molecular hydrogen bonding. MG-blocks contain 
both equatorial-axial and axial-equatorial linkages, but the differing degrees of freedom of the 
two residues gives greater overall flexibility than the (1→4) linked β-D-mannuronate chains 
(Figure 4c). Hence, the stiffness of the chain blocks has been found to increase in the order 
MG < MM < GG [56-58].  
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Figure 4. Alginate chemical structure. (a) Illustration of the Haworth formulas of the two monomers. M = 
β-D-mannuronic acid and G = α-L-guluronic acid. (b) Block composition in alginates. (c) Ring 
conformation in the alginate chain (4C1 for M and 1C4 for G). Stretched ribbon-like structures are formed 
by equatorially linked poly-mannuronate chains (top) while axially linked poly-guluronate chains tend to 
assemble in folded ribbons (zigzag-shaped chain conformation, bottom). The cavities between each pair 
of guluronate residues present favorable binding sites for cations. Ring protons are not shown.   
 
The composition and sequential structure of alginate is often a key functional attribute, and 
variations in the composition and/or the sequential structure may cause differences in 
performance of an alginate for a particular end use. As alginates are macromolecules of 
heterogeneous structure with no regular repeating unit [59] the alginate molecule cannot be 
described by the monomer composition alone. In stead, detailed information about the 
structure of alginates can be gained from high-resolution 1H- and 13C-nuclear magnetic 
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resonance spectroscopy (NMR) techniques [60-62]. Thus, the fraction of guluronic and 
mannuronic acid in an alginate sample (FG and FM, respectively) together with information 
about diad and triad frequencies and information about the average G-block length can be 
determined (see section 1.3.5).  
 
In algal alginates FG can vary in the range of 0.20 to 0.85 [63]. High contents of G is 
generally found in alginates prepared from stipes of old Laminaria hyperborea plants, 
whereas alginates from Durvillea antartica, Ascophyllum nodosum, Laminaria digitata and 
Macrocystis pyrifera are characterized by a low content of G-blocks [42]. Even more extreme 
composition can be found in alginates isolated from bacteria strains of Azotobacter vinelandii 
or Pseudomonas [63]. Azotobacter alginates resemble the seaweed material in that they are 
true block copolymers (FG = 0.10-0.95), whereas Pseudomonas alginates invariably lack G-
blocks (FGG = 0). The main differences between the bacterial and algal alginates are however 
the presence of O-acetyl groups in the former which influence the swelling and water-binding 
potential of bacterial alginate gels [63, 64].  
 
Alginates are polydisperse with respect to molecular weight, and because of this the 
molecular weight of the polymer is an average of the whole distribution of molecular weights. 
Depending on the end use and the sensitivity of the application to the molecular mass, the 
presence of a wide range of alginate fractions may be an issue. In such cases, calculation of 
the polydispersity will be important, and in general, a narrow molecular weight distribution is 
preferred [42].  
 
In its native form, the polymer chains of alginate are rather long. However, being a single 
stranded polymer alginate is susceptible to a variety of depolymerization processes. The 
glycosidic linkages are cleaved by both acid and alkaline degradation mechanisms and by 
oxidation with free radicals. As a function of pH, degradation of alginate is at its minimum at 
neutrality and increases at low pH due to proton catalyzed hydrolysis [65] and at high pH due 
to β-alkoxy-elimination [66]. Degradation by free radicals is mainly due to oxidative-
reductive depolymerization reactions caused by contamination of reducing agents like 
polyphenols from the brown algae [53]. All these depolymerization reactions increase with 
temperature. During processing, the molecular weight will hence decrease and is rarely higher 
than 500,000 g/mole for commercial alginates. 
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1.3.3 Physical properties 
The industrially important properties of alginates are mainly a result of the macromolecular 
and polyelectrolytic character of the molecule. As there is a strong correlation between 
structure and function of alginates, the chemical composition and molecular weight of the 
molecule will determine alginate’s applicability for commercial uses.  
 
Viscosity 
The viscosity of an alginate solution will mainly depend on the molecular weight and 
concentration of the polymer sample. However, as the intrinsic flexibility of the chain blocks 
varies, the composition might also affect the final viscosity of the solution. Since alginate is a 
highly negatively charged polyelectrolyte, the electrostatic repulsion between the charged 
groups will further contribute to viscosity by forcing the molecule into a very extended 
random coil conformation [67]. Consequently, the ionic strength of the solution will be of 
importance in this aspect as high ionic strength will lead to shielding of the charges and hence 
reduced chain extension. It has been shown that the intrinsic viscosity, [η], of an alginate 
solution is linearly dependent on the ionic strength in the solution [42, 68].  
High molecular weight has been shown to be beneficial for several applications of alginate. 
However, the use of very high molecular weight materials is limited by their high viscosity, 
e.g. making sterile filtration and general handling of the solution difficult. In addition, it has 
been reported that very high viscosity alginate solutions may reduce cell viability due to the 
high shear-forces required to mix cells with these solutions [69]. 
 
Solubility 
Sodium alginate and most other alginates of monovalent metals are soluble in water and give 
solutions of high viscosity. However, the pH of the solvent is an essential parameter 
determining the solubility of alginates in water as it will influence the presence of electrostatic 
charges on the uronic acid residues [70]. As a result of this, alginic acid, the protonized form 
of alginate, is generally insoluble in water [68] forming either gels or precipitates [71, 72]. 
The pKa values of the two monomers have been determined as 3.38 for M and 3.65 for G (in 
0.1M NaCl), and consequently the pKa of the polymer increases with increasing G content 
[73]. The solubility of an alginate sample at low pH is, however, not necessarily a direct effect 
of the pKa [70]. High amounts of polyalternating structure in an alginate sample has been 
shown to increase its solubility at low pH [74]. In fact, a sample of pure polyalternating 
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structure was demonstrated to be completely soluble over the whole pH range at short 
equilibration times [70]. The reason for this was suggested to be structural, based on the 
irregularities of the axial/equatorial linkages in the alternating sequences [70].  
In addition to the pH being important for alginate solubility in water, the ionic strength of the 
solute and the presence of divalent ions play important roles due to salting out effects and 
gelling, respectively [75]. 
 
Ion binding  
Present and future applications of alginates are mainly linked to the most striking feature of 
the alginate molecule – the formation of an ionotropic gel in the presence of certain 
multivalent cations like Ca2+, Ba2+ and Sr2+. The binding of ions is highly selective and the 
affinity strongly depends on the alginate composition [54]. The affinity of alginates for 
alkaline earth metals has been shown to increase in the order Mg2+ << Ca2+ < Sr2+ < Ba2+ [76]. 
More specifically, from experiments involving equilibrium dialysis of alginate [54, 76, 77] it 
was found that the selectivity for alkaline earth metals increased markedly with increasing G 
content, but that MM and MG blocks were almost without selectivity. Smidsrød [54] reported 
that the binding strength of divalent ions to the three alginate fragments is as follows:  
 
GG-blocks:  Ba > Sr > Ca >> Mg  
MM-blocks:  Ba > Sr ~ Ca ~ Mg 
MG-blocks:  Ba ~ Sr ~ Ca ~ Mg 
 
The high selectivity between similar ions indicates that interactions between alginates and 
these ions are not purely electrostatic. Rather, a complexing of ions related to the structure of 
G-blocks is taking place [41]. The mechanism has been explained by an “eggbox” model [78-
81] where the diaxially linked G residues form cavities which function as binding sites for 
ions, like eggs in an eggbox (Figure 5). When sequences of G-blocks form bonds with similar 
sequences on the same or other molecules junctions are formed as illustrated in Figure 5, 
creating a gel network. More recent work suggests lateral association far beyond a pure 
dimerization of chains which increases with increasing [Ca2+] and G content (Figure 5b) [82, 
83].  
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Figure 5. Binding of divalent ions to alginate – the eggbox model. (a) Chelation of divalent 
cations. (b) Lateral association of chains. 
 
The gel formation is irreversible and autocooperative, physically explained by the entropically 
unfavorable binding of the first divalent ion between two G-blocks and the more favorable 
binding of the following ions (zipper mechanism) [75]. The minimum required size of 
adjacent G units for formation of stable junctions has been reported to range from 
approximately 8 to 20 G residues for Ca2+ [84, 85]. Further, it has been reported that the 
minimum length of G blocks necessary for junction formation decreases with increasing 
affinity of ions toward the alginate chain [86]. Hence, the length of G-blocks is of great 
importance for the formation of stable junctions. 
 
1.3.4 Alginate gels  
An alginate gel, like many other biopolymer gels, is a continuous biopolymeric network 
swollen with water where the network is bound together by non-covalent crosslinks  - a so-
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called “physical gel” [87]. The properties of alginate gels are largely governed by factors such 
as chemical composition, sequence, molecular weight and molecular weight distribution of 
the polymer [53]. 
  
Formation of gels 
When a solution of sodium alginate comes into contact with calcium or other divalent cations, 
a rapid, strong and irreversible formation of a gel takes place. The formation of alginate gels 
is special in the sense that it is independent of temperature, and the resulting gels are heat 
stable [41].  
There are two fundamentally different methods for preparing alginate gels by ionic 
crosslinking: The diffusion method and the internal gelation method. The methods differ in 
the way the crosslinking ion is introduced [41, 75] and hence the gelling kinetics of the two 
methods is very different. 
The diffusion method is characterized by allowing calcium (or other divalent ions) diffuse 
from an outer reservoir into the alginate solution (Figure 6). Although this method is widely 
used in food industry [51], it has also become a very popular method as an immobilization 
technique. The method is very rapid and will result in an inhomogeneous distribution of 
alginate as discussed in the section covering alginate beads.  
The internal gelation method is based on the mixing of an inactive form of the crosslinking 
ion with alginate solution (Figure 6). For calcium the insoluble CaCO3 or Ca2+ ions 
complexed with chelating agents like EDTA or citrate can be used. The Ca2+ ions are released 
by lowering the pH adding organic acids or slowly hydrolyzing lactones. This method allows 
for a slow and controlled formation of gels and will almost always result in a homogenous 
distribution of alginate within the gel. Using a system of alginate mixed with CaCO3 and 
GDL (D-glucono-δ-lactone) the gelling kinetics can be controlled by the calcium carbonate 
particle size. In addition, the pH of the final gel may be easily set by adjusting the relative 
proportions of calcium salt and GDL [88]. The gel strength and breaking strength of internally 
set gels will also in general be lower compared to diffusion gels as the former usually are 
calcium limited [41, 89]. 
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Figure 6. Principal differences between the diffusion method (exemplified by a capsule) (top) and the 
internal gelation method (bottom). Adapted and modified from [41]. 
 
Syneresis 
Binding of multivalent cations to a binding site on alginate is rapid, and probably results in a 
certain degree of sub-optimal crosslinking in alginate gels [50]. Building a network structure 
of perfectly aligned blocks to form the maximum possible number of interguluronate sites is 
limited by diffusion of the polymer chains. To get a higher degree of overlap it is necessary 
for a series of slow dissociation/association steps to occur after the initial crosslinking, and 
alginate gels are hence said to be non-equilibrium gels [90].  
The shrinkage of hydrogels with the concomitant release of water is referred to as syneresis. 
The result of syneresis is a smaller gel with a higher total concentration of alginate. Syneresis 
is highly dependent on alginate composition. Alginates containing long G-blocks will shrink 
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less during gel formation than alginate with shorter G-blocks due to the formation of strong 
irreversible junctions in the former, hindering reorganization of the network structure [91]. 
Alginates containing high amounts of alternating structures will, however, undergo great 
syneresis due to the larger flexibility of the MG-blocks, allowing denser packing and thus 
further intra- and intermolecular crosslinking [91-93]. Up to a certain point, syneresis also 
increases with increasing [Ca2+] [91], increasing gelling time [91] and increasing molecular 
weight [93].  
Application of small-angle X-ray scattering techniques (SAXS) has provided information 
about the lateral thickness of junction zones in alginate gels [82, 94, 95]. In these studies, an 
increase in syneresis is illustrated upon lateral aggregation of junction zones.  
 
Mechanical rigidity of alginate gels 
The elasticity of a gel is a measure of its deformation under stress and is often described by 
rubber elasticity theory. This theory is based on rubber-like (entropic) networks which are 
crosslinked by stable, covalent bonds where the crosslinks are point-like and allowed to move 
freely in the elastic body under the elastic influence of the chains. Upon deformation of the 
gel, the free energy change is caused by the decrease in entropy, solely [96, 97]. In an alginate 
gel network, however, the crosslinks are not point-like, but rather composed of long, non-
permanent junctions where the chains between junctions are very restrictive in their 
movements. In fact, it has been shown [98, 99] that upon deformation the entropy of alginate 
gels increases rather than decreases as should be expected from the theory of rubber elasticity. 
This has been explained by the rupture and movement of junctions upon deformation, 
meaning that the elasticity of alginate gels is energetic rather than entropic in origin [98-100].  
 
The elastic modulus (or Young’s modulus) is frequently used as a measure of gel strength for 
alginate gels. In general, the elastic modulus will depend on the number and strength of 
crosslinks as well as on the length and stiffness of the chains between crosslinks [75]. Hence, 
the gel strength has been shown to be a function of composition, molecular weight, polymer 
concentration and type of ions used for crosslinking.  
Increased ion binding and hence also enhanced mechanical rigidity is found with alginates 
rich in G residues [101]. In general, G-rich alginates form stronger gels than alginates high in 
mannuronic acid. Specifically, the mechanical strength increases with the length of G-blocks 
stemming from association of long G-blocks and a shortening of the elastic segments [88, 
102, 103].  
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As the gel strength increases with the affinity between polymer and crosslinking ion, the 
modulus depends on the type of divalent ion used for gelation [54]. It has been reported that 
the minimum length of G blocks necessary for junction formation decreases with increasing 
affinity of ions toward the alginate chain [86], probably resulting in an increased number of 
elastic chains per unit volume. The increase in mechanical strength with ion affinity may thus 
be due to a combination of higher strength or higher number of junctions [90]. 
For Ca-saturated alginate gels made by diffusion the modulus increases with molecular 
weight up to a certain point. The gel strength becomes constant when intrinsic viscosity 
exceeds approximately 600 ml/g [91]. The modulus of Ca-limited gels is, however, more 
molecular weight sensitive [89].    
Young’s modulus has been shown to be proportional to the square of alginate concentration 
[102]. As alginates undergo syneresis to various extents, the concentration differences have to 
be taken into account when calculating the Young’s modulus [91].  
 
The force needed to rupture a gel can also be used for describing the mechanical properties of 
alginates gels. Whereas the elastic modulus is determined at small deformation, the rupture 
strength gives information about the gel behavior at large deformation. As both the modulus 
and rupture strength will be correlated to the number of crosslinks in the network, it might be 
expected that in general the rupture strength will increase with the apparent modulus. 
However, rupture strength is not necessarily related to its elastic modulus [104, 105]. A low-
modulus M-rich alginate will typically show high rupture strength (high elasticity), whereas a 
high-modulus G-rich alginate will show lower rupture strength (brittle consistency) [75, 91]. 
For a G-rich alginate the shorter, stiffer polymer chains between junctions transmit more 
energy to the junction zones upon compression, thus facilitating rupture. A junction carrying 
the highest stress, normally the shortest one in length, fractures first and the energy released 
from the fractured junction will transfer to the neighboring chains, accelerating the break of 
other junctions [106]. 
Rupture strength, like the modulus, is very dependent on molecular weight, increasing with 
increasing MW, but does not become constant above a certain value [75].  
 
The elastic modulus and rupture strength can be determined by compression measurements of 
gel cylinders to rupture. Young’s modulus (E) is calculated from the slope of the initial zone 
of the resulting stress-strain curve, representing the behavior of an elastic spring obeying 
Hook’s law [107]. E is defined as [108]: 
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F/A = E · (Δl/l)                    (1-1) 
 
where F is the force needed to compress a material with a contact surface A a length Δl of the 
total length l.  
 
Alginic acid gels 
Under controlled conditions alginates form acid gels rather than participates at pH below the 
pKa value of the uronic acid residues. The gels have been proposed to be stabilized by 
intermolecular hydrogen bonds. As for ionically crosslinked gels, the chemical composition 
and monomer sequence is important for the physical properties of acidic gels. However, in 
contrast to ionically cross-linked gels, alginic acid gels are equilibrium gels [41, 72]. With the 
exception of some pharmaceutical uses, the number of application for alginic acid gels is so 
far limited [48].  
 
1.3.5 Physical and chemical characterization of alginate  
One of the main advantages of using alginate for immobilization purposes is that they have 
been extensively studied over many decades. The characterization of alginates is feasible 
through numerous well-known methods. The most important methods used for 
characterization of alginate in the present study are presented shortly in the following. 
 
Chemical composition and sequence 
Alginate protons or carbons will absorb energy at various frequencies depending on their 
position in the alginate, and on the neighboring monomers. The four diad (nearest neighbor) 
frequencies, FGG, FGM, FMG and FMM, and the eight possible triad (next nearest neighbor) 
frequencies, FGGG, FGGM, FMGG, FMGM, FMMM, FMMG, FGMM and FGMG can thus be determined 
by high-resolution 1H- and 13C-nuclear magnetic resonance spectroscopy (NMR) techniques 
[60-62]. An example of a typical 1H-NMR spectrum is shown in Figure 7. 
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Figure 7. 1H-NMR spectrum of a Laminaria hyperborea stipe alginate (FG>0.7). 
 
The molar fractions can be calculated from integration of characteristic signals and the 
following relations:  
  
FGG + FMG = FG                   (1-2) 
FMM + FMG = FM                   (1-3) 
FGG + FMM + FGM + FMG = 1                  (1-4) 
 
For long chains, where the contribution from the end-groups can be neglected, FMG = FGM.  
From this, the average length of G-blocks (larger than 1 unit), which has been shown to 
correlate well with gelling properties, can be calculated: 
 
Although NMR technology is a very powerful tool, it has been limited to giving information 
on the average length and distribution of blocks only. Recent development in the field of 
polysaccharide sequencing allows for a more detailed characterization. The true 
reconstruction of the block structure of alginates can be assessed by the use of specific 
alginate degrading enzymes (lyases) and subsequent analysis of the digest. After fractionation 
of the digest by size exclusion chromatography (SEC), the composition and molecular mass 
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of each fraction is analyzed by NMR and ESI-MS (low molecular weight fractions) or 
HPAEC-PAD/MALDI-TOF-MS for the high molecular mass fractions [109].   
 
Molecular weight and molecular weight distribution 
Commercial alginates are polydisperse with respect to molecular weight. Hence, the 
molecular weight is expressed as averages over the whole distribution of molecular weights 
either as the number average ( nM ) or the weight average ( wM ). In a polydisperse molecule 
population, the relation wM > nM  is always valid, while for a monodisperse molecule 
population we have wM = nM . For a randomly degraded polymer, nw MM 2≈ [110]. The 
polydispersity index is given by the fraction nw MM /  gives information about the molecular 
weight distribution in an alginate sample. Values have been reported for alginates ranging 
from 1.4 to 6.0 [48], but are typically between 1.5 and 3.0 for commercial alginates. 
nM  and wM  may be determined e.g. by size exclusion chromatography with multiple angle 
laser light scattering detection (SEC-MALLS). Measurements of the intrinsic viscosity can 
also give information about the molecular weight through the Mark-Houwink-Sakurada 
equation [111] (see below).   
 
Intrinsic viscosity 
The intrinsic viscosity [η] describes a polymer’s ability to form viscous solutions in water 
under specified solvent and temperature conditions. It is determined by measuring the efflux 
time of a polymer solution at a series of concentrations in a capillary viscometer.  
The intrinsic viscosity is directly related to the molecular weight of a polymer through the 
Mark-Houwink-Sakurada (MHS) equation [97]:  
 
[ ] avMK ⋅=η                     (1-6) 
 
where K is a constant, vM  is the viscosity derived average molecular weight, and a is an 
empirical constant describing the conformation of the polymer and increases with increasing 
chain extension. For alginate, the exponent (a) is close to unity at an ionic strength of 0.1 (for 
example, 0.1 M NaCl). For a = 1, wv MM = . For a < 1, wvn MMM <<  [97]. By 
determining the intrinsic viscosity, the viscosity average molecular weight can be determined 
if K and a are accurately known for the sample. However, as a and K will by highly affected 
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by the stiffness of the chains, their values will greatly depend on the composition and 
sequential structures in alginate [111].  
 
1.4 C-5 Epimerases 
In brown algae as well as in the alginate producing bacteria, alginate is initially produced as 
polymannuronic acid (FM = 1.0) [112]. The final step in alginate biosynthesis, however, 
involves a unique process: The extracellular C-5 epimerization of mannuronic acid to 
guluronic acid at the polymer level [113, 114]. This in-chain conversion of M to G residues is 
catalyzed by the mannuronan C-5 epimerases (Figure 8), without breaking the glycosidic 
linkages. Post-polymer epimerization of polysaccharides is a relatively rare event which in 
nature is, in addition to alginate biosynthesis, only known to take place in the biosynthesis of 
the glycosaminoglycans heparin/heparin sulphate [115] and dermatan sulphate [116] in the 
conversion of D-glucuronic acid into L-iduronic acid [117]. 
 
 
Figure 8. The proposed mechanism for mannuronan C-5-epimerase [118]. The result of the 
epimerization reaction is the conversion of mannuronic acid to guluronic acid with the subsequent 
change in ring conformation from 4C1 (in ManA) to 1C4 (in GulA), maintaining the large, bulky carboxyl 
group in the equatorial position. 
 
The presence of C-5 epimerase was first demonstrated in A. vinelandii [119, 120] and has now 
also been reported in Pseudomonas aeruginosa [114] and Pseudomonas syringae [121] as 
well as in a wide range of brown algae [122]. In the early investigations, the enzyme was 
reported to introduce single G residues or homopolymeric blocks of G, depending on the 
concentration of calcium ions [120, 123]. Screening of an A. vinelandii gene library has, 
however, proved the existence of a family of seven mannuronan C-5-epimerase genes, the 
algE genes (algE1-algE7) which all have been sequenced and expressed in Escherichia coli 
[124-126]. The protein products of the algE genes, the AlgE epimerases, vary in both size and 
activity. The activities of the enzymes are highly Ca2+-dependent, but do not require co-
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factors like NAD+/NADH [120]. Based on the epimerases studied so far, it is clear that each 
enzyme catalyzes the production of alginates with distinct monomer distribution patterns. The 
AlgE4 epimerase catalyzes the formation of MG-blocks exclusively, while the remaining six 
enzymes introduce a mixture of continuous stretches of G residues and alternating sequences 
[127]. 
 
1.4.1 Structure and function of C-5 epimerases 
The seven C-5 epimerases (AlgE1-AlgE7) all contain repeats of two types of structural units, 
designated A and R. Both modules are highly conserved at the amino acid sequence level 
among the members of the protein family. Due to the variability in the number of A and R 
repeats in the algE genes, the molecular weights of the AlgE epimerases vary in the range of 
57.7-191 kDa [128] (Figure 9).   
 
 Module structure  [kDa] Products 
AlgE1 
 α β γ  ε 
A1 R1 R2 R3 A2 R4  
147.2 G- and MG -blocks 
AlgE2 
 α β γ δ 
A1 R1 R2 R3 R4  
103.1 G-blocks (short) 
AlgE3 
 α β γ  α β γ δ 
A1 R1 R2 R3 A2 R4 R5 R6 R7  
191.0 G- and MG-blocks 
AlgE4 
 ε 
A1 R1 
57.7 MG-blocks 
AlgE5 
 α β γ δ 
A1 R1 R2 R3 R4  
103.7 G-blocks (medium) 
AlgE6 
  ε ε ε 
A1 R1 R2 R3  
90.2 G-blocks (long) 
AlgE7 
  ζ η δ 
A1 R1 R2 R3  
90.4 
G-blocks, MG-blocks 
and lyase activity 
 
Figure 9. The modular structure, molecular mass and enzyme activities of the extracellular mannuronan 
C-5 epimerases AlgE1-AlgE7 from A. vinelandii. Each mannuronan C-5 epimerase is composed of 
different numbers of A modules (385 amino acids) and R modules (153 amino acids), designated A1-A2 
and R1-R7. Closely related A-modules are indicated with identical shading. Closely related R-modules are 
indicated with identical Greek letter (α, β, γ, δ, ε, ζ, η) [42]. 
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The A modules are present in 1-2 copies in each epimerase [127] and have shown to contain 
the substrate-binding site [129]. Their function is to catalyze the epimerization reaction, and 
hence determine the final distribution of M and G in the end product. The R modules are 
present in 1-7 copies [124, 125] and probably modulate the enzyme-substrate binding strength 
[129]. The A and R modules both contain Ca2+ binding motifs [130].    
 
Since all alginates found in nature are produced by the C-5 conversion of homopolymeric 
mannuronan, the structural variability found in the polysaccharide originates from the 
different catalytic properties of the various epimerases [126]. While AlgE2 [131] and AlgE5 
[109] make relatively short G-blocks, AlgE1 and AlgE6 make longer G-blocks [109]. In 
addition to G-blocks, AlgE1 and AlgE3 can introduce alternating structure in the polymer 
chain [109, 127, 132]. However, AlgE4 produces strictly alternating MG sequences [128, 133, 
134]. AlgE5 and AlgE7 are combined epimerase and alginate lyases [109, 135]. As none of 
the AlgE epimerases are capable of epimerizing acetylated mannuronan residues found in 
bacterial alginates, acetylation may play a part in the epimerization pattern in the final product 
[63]. 
 
The biological function of all the epimerases is not yet fully understood. However, since A. 
vinelandii requires alginates of varying composition under different environmental conditions 
and different stages of its life cycle, it seems possible that the organism can control the 
expression of its epimerase genes as a response to certain environmental signals. It is believed 
that Ca2+ levels determine the relative activity of the enzymes as the epimerases have different 
activity at different calcium concentrations [63, 126, 136] 
Until recently, there was limited knowledge about the epimerases in algae. However, 
epimerases from Laminaria digitata have now been isolated, with structural similarities to the 
bacterial C5-epimerases [137]. Depending on the season, age of the plant and tissue type, 
different epimerases are likely required in order to tailor the relative contents and distributions 
of G-, M- and MG-blocks in the polymer chains. It is reasonable to believe that this way of 
controlling the physical properties of alginates is widespread in nature [63, 126].   
 
1.4.2 Large scale production of recombinant epimerases and bacterial alginate 
As the mannuronan C-5 epimerases are not yet commercially available they have to be 
expressed recombinantly and purified. The production of epimerases is performed by 
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intracellular over-expression using different E.coli strains containing plasmids encoding the 
epimerase of interest. The enzymes are purified by sonication of the cells, centrifugation, 
filtration and application on an ion-exchange column before the fractions are analyzed for 
activity [132, 138]. The purified enzymes can then be used for modification of alginate in 
vitro (see below) and the outcome of the epimerization reaction determined by NMR 
spectroscopy of the alginate prior to and after epimerization [138]. 
 
The use of mannuronan as substrate for in vitro epimerization opens up the possibility for 
production of perfectly tailored alginates not found in nature. In addition, the availability of 
mannuronan is important for the extensive studies of the AlgE epimerases. It has been shown 
that P. aeruginosa synthesizes an epimerase encoded by algG and that epimerase defective 
mutants of AlgG produce polymannuronic acid [114]. In fact, this organism served as the first 
source of mannuronan. However, as P. aeruginosa is an opportunistic human pathogen [136], 
the recent availability of large quantities of mannuronan (FM = 1.0) stems from the non-
pathogenic epimerase negative AlgG- strain of P. fluorescens [139]. High molecular weight 
mannuronan is produced by fermentation using fructose as carbon source [138]. 
 
1.4.3 In vitro epimerization for biotechnological applications 
Since the epimerases alone decide the composition of M and G in the final alginate, the 
epimerization is the key reaction affecting the alginate structure and thus the ion-binding and 
gel-forming properties of the alginates. For this reason, the epimerase gene family presents 
many possibilities for both basic and applied research. It has previously been shown that the 
enzymes can be used to modify alginates giving rise to polymers with enhanced gelling 
properties [92, 103]. Another interesting prospect is the use of in vitro C-5 epimerization to 
reduce the compositional heterogeneity in an alginate sample. As algal alginates may vary 
from plant to plant and from one tissue to another, commercial alginates are mixtures of 
subpopulations of molecules with great compositional and structural heterogeneity. Treatment 
of commercial alginates with C-5 epimerases may result in a more uniform distribution of 
composition and block structure thereby improving their physical properties [53, 63]. For 
example, as it has been shown that M-blocks are potent stimulators of the immune system 
[140], homogeneous alginates with few M-blocks produced by selected epimerases may be 
better suited for implantation in humans than the heterogeneous commercially available 
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alginates. However, as the available epimerases are produced in bacteria, the requirements for 
extensive purification of the in vitro epimerized alginate products will be high.   
Due to their ability to form strong gels, alginates rich in G-blocks are particularly in demand. 
So far, these alginates have exclusively been obtained from Laminaria hyperborea stipes, 
which represent a limited source. As AlgE1 and AlgE6 have shown to epimerize polyM- and 
polyMG-alginate to a G-content of 90 and 97 % respectively [109], these epimerases may 
become valuable tools for tailoring G-block alginates in future products. Hence, recombinant 
epimerases have great potential as tools for producing unique alginates - for new applications, 
as well as in traditional industrial products. 
 
Recently, with the use of a combination of various high-tech tools [134, 141-144], more 
knowledge has been gained on the mode of action and substrate specificity of the C-5 
epimerases. In these studies, AlgE5 was for instance shown to prefer polyMG as substrate 
whereas AlgE1 and AlgE6 prefer mannuronan or substrates containing G-blocks [109]. The 
difference between AlgE1 and AlgE6 with regard to length and distribution of the G-blocks 
they introduce was also illustrated and explained by their different degree of processivity 
[109]. Knowledge about the epimerization patterns and substrate specificities opens up the 
possibilities for an even more specific tailoring of alginates. By this means, the length and 
distribution of blocks in the alginate can be controlled, further improving the performances in 
a number of applications [109]. 
 
Complete knowledge about the structure-function relationships of all the modules hold 
promise to the future creation of new epimerases with desired technical properties. This could 
be done by site-specific mutagenesis or by exchanging modules or parts of modules between 
different epimerase genes. The resulting epimerases could then be utilized to epimerize 
alginate in vitro or in vivo [136]. However, the obvious drawback of in vivo epimerization 
would be the lack of control of the end product compared to in vitro modifications [127].  
 
The AlgE4 epimerase 
Of all the C-5 epimerases isolated from Azotobacter vinelandii, AlgE4 is probably the most 
studied enzyme [58, 70, 92, 93, 128, 129, 133, 134, 143-146]. In particular, the very recent 
availability of a pure polyalternating sample, made by AlgE4 epimerization of mannuronan, 
can facilitate the study of the role of alternating structures in solution and in the gel state. It 
has been shown that the alginate product of AlgE4 epimerization possesses some rheological 
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qualities that can be advantageous in certain applications. Introducing alternating sequences in 
calcium alginate gels leads to a faster sol/gel transition and a considerably larger syneresis. 
The gel strength has also shown to increase slightly by epimerization [92]. The effects have 
been explained by the reduction of the stiffness of the polysaccharide chain due to the 
intrinsically higher flexibility of MG compared to GG and MM diads. 
 
On a polymannuronic backbone, the AlgE4 introduces G entirely in an alternating matter, to a 
total G-content of 45-47%. A theoretical value of 50% conversion is not achieved as the 
epimerase does not convert the last few M residues on chain ends [143]. It has been found that 
in alginates already containing G-blocks, a few G residues can be introduced next to a pre-
exciting G, thus contributing to an elongation of the G-blocks [92, 128].  
 
During AlgE4 epimerization the fraction of GMG blocks increases linearly as a function of 
the total fraction of G residues and comparably much faster than that of MMG blocks. This 
suggests that the enzyme epimerizes alginate by a non-random mechanism either by sliding 
along the alginate chain (processive mechanism) or by recognizing a pre-existing G residue as 
a preferred substrate in its repeated attacks [128]. More recent studies using time-resolved 
NMR spectroscopy [134], mathematical modeling [133] and atomic force microscopy [144] 
suggested that AlgE4 is processive. Further, it has been demonstrated that on average 10 
residues are epimerized for each enzyme-substrate encounter and that a minimum size of 6 
residues is required for AlgE4 activity [143]. 
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1.5 Alginate microcapsules 
1.5.1 Formation of alginate microbeads/capsules  
Of the many proposed technologies for encapsulation of cells, the use of alginate gel 
microbeads stands out so far as one of the most promising and versatile method [4, 24, 147]. 
One of the main reasons for this is the simplicity of the method where the immobilization 
procedure can be carried out in a single step process and does not require a deep expertise in 
related fields of polymer chemistry, membranes, hydrogels and networks. However, it should 
be kept in mind that oversimplification over the past years has been shown to result in 
irreproducible results and information noise [24] which in some cases could have been 
avoided with more knowledge on the biopolymer and capsule technology.  
The entrapment is carried out by mixing an aqueous solution of sodium alginate (1-4 %) with 
cells, and dripping the mixture into a solution containing divalent cations such as Ca2+, Sr2+ or 
Ba2+ (20–100 mM). The divalent ions will diffuse into the sodium alginate droplets, 
instantaneously forming hydrogel spheres entrapping the cells within a three-dimensional 
lattice of ionically crosslinked polymer (< 5 min for beads of 500 μm [148]). The size of the 
resulting capsules is determined by the size of the droplets. Simple devices can be used to 
prepare gel beads in sizes ranging from a few microns to >5 mm [4]. Evenly sized microbeads 
with diameters below 1 mm and down to < 200 μm can be formed by establishing an 
electrostatic potential of 1-20 kV between the needle feeding the alginate solution and the 
gelling bath using an electrostatic bead generator (Figure 10). The electrostatic potential pulls 
the droplets from the needle tip into a gelling bath. The potential can be static [149, 150]. In 
addition to needle size, adjusting the voltage magnitude easily controls the droplet size. The 
viscosity and flow rate of the alginate solution will also influence the capsule size [151]. 
 
Other encapsulation techniques include [152]: 
Extrusion through a needle: Alginate solution is dripped from a syringe with appropriate 
diameter needle directly into a gelling bath. While this method does not require any 
instrumentation, the size and size distribution of the produced beads are difficult to control. 
Coaxial air or liquid flow: The coaxial air jet system is a simple way of generating small 
beads (down to around 500 μm), although the size distribution will normally be larger as 
compared to an electrostatic system. A coaxial air stream is used to pull droplets from a 
needle tip into the gelling bath. 
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Vibrating jet breakage: A vibrating nozzle generates drops from a pressurized vessel. 
Rotating jet breakage: Bead generation is achieved by cutting a solid jet of fluid coming out 
of a nozzle by means of a rotating cutting device. The fluid is cut into cylindrical segments 
that then form beads due to surface tension while falling into a gelling bath. 
Emulsification methods:  An emulsion of alginate in oil can be added to a CaCl2 solution, 
leading to bead formation. However, the particle size cannot be easily controlled and the 
capsules tend to coagulate into large masses before hardening properly [153].   
 
    (a)         (b) 
 
 
Figure 10.  (a) Encapsulation of cells using an electrostatic capsule generator. Cells are mixed with an 
alginate solution and fed by a syringe pump (not shown). The voltage is coupled to the gelling bath and 
the alginate feeding-needle to earth. The distance between the needle and the gelling solution can be 
adjusted.  (b)  A representative capsule population of empty capsules made with the electrostatic capsule 
generator.  The capsule diameter is approximately 0.5 mm. 
 
As alginates are negatively charged polymers, they form strong complexes with polycations 
such as polysaccharides (e.g. chitosan) [154-156], polypeptides (e.g. poly(L-lysine) [34, 157], 
poly(L-ornithine) [158]) or synthetic polymers (e.g. poly(methylene-co-guanidine) [159, 160] 
and poly(ethylene imine) [161, 162]). As these complexes do not dissolve in the presence of 
non-gelling cations or calcium chelators they have been extensively used to stabilize the gel 
and reduce the porosity of Ca-alginate beads. Of all the polycations used for this purpose, 
poly(L-lysine) is the most extensively studied since it was first proposed in the original paper 
by Lim and Sun [34] describing the encapsulation of islets of Langerhans. In fact, it has been 
estimated that approximately 90% of all publications on cell encapsulations have involved the 
use of PLL with or without modifications of the original capsule [163]. 
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The variations in the procedures of forming an alginate/polycation membrane are wide. The 
most common method is to use a three-step procedure (Figure 11) where alginate beads are 
first produced by gelling of alginate droplets in calcium chloride. After gelling, the second 
step is to transfer the beads into a solution of polycation, forming a capsule with a 
polycation/alginate complex membrane around the beads. Polycations like poly(L-lysine) are 
cytotoxic and immunogenic and their positive charge will also lead to attachment of cells to 
the surface. Hence, for transplantation purposes, it is necessary to apply an additional layer of 
alginate or other coatings to neutralize any excess of positive charges on the capsule surface 
[164, 165].  
 
 
 
Figure 11. Schematic description of the treatment of alginate beads to form alginate-polycation capsules. 
The method is exemplified with poly(L-lysine) as polycation followed by coating with an outer alginate 
layer to shield the positive charges on the alginate-PLL capsule. In reality the polycation forms complexes 
with both the alginate core and coating [166], resulting in two layers (alginate core and alginate-
polycation complex) rather than the three separate layers shown in the figure.  
 
The original capsule designed for immobilization of islets [34] was based on a liquid core 
capsule. In this system, the crosslinking ions (Ca2+) are exchanged with non-gelling Na+ ions 
Poly-L-Lysine (PLL)
3 x washing in physiological saline
Ca-alginate gel bead
Alginate
3 x washing in physiological saline
Alginate-PLL capsule
Alg-PLL-alg capsule
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by sequestering agents like citrate, dissolving the gel core. This will give a polyanion-
polycation complex that behaves as a semi-permeable membrane. Since that time, many 
groups have utilized this system and some authors claim improved cell viability in these 
capsules [167]. However, the obvious drawback is an increased osmotic pressure and less 
elastic strength inside the liquid capsule, decreasing the mechanical stability of the capsules 
[167, 168]. Many modifications of the original alginate microcapsule have emerged over the 
past years including the use of other polycations [160, 169], formation of multilayer capsules 
[170], addition of an outer alginate gel (mic/mac) [171], surface modification on the 
alginate/polylysine membrane [172] and exclusion of the polycation layer forming a simple 
Ca- or Ba-alginate gel bead [173-176].  
 
1.5.2 Alginate microcapsules for treatment of Type 1 diabetes 
The possible uses of alginate for immobilization of living cells in food industry, medicine and 
agriculture are numerous, ranging from ethanol and beer production by yeast cells [177, 178], 
to the production of pharmaceuticals such as antibiotics and steroids [179]. On an industrial 
scale, immobilized cells are much easier to handle than free cells [180]. In addition, higher 
viability, stability, productivity and proliferation have been reported for some immobilized 
cell systems [181-183]. However, of all the cells used in alginate immobilization systems, 
major interest has been devoted to insulin producing cells for the treatment of Type 1 diabetes 
[34, 184] which is the main focus in the following sections. 
 
Insulin is a hormone essential for normal glucose homeostasis, secreted by the β-cells within 
cell clusters known as islets of Langerhans in the pancreas [185]. Diabetes is characterized by 
disordered metabolism and inappropriately high blood sugar (hyperglycemia) resulting from 
either low levels of insulin or from abnormal resistance to insulin’s effects. The disease is one 
of the leading causes of morbidity and mortality worldwide [186] and is currently considered 
as an epidemic disease due to the fast increasing cases globally. In fact, the total number of 
people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030 
[187]. 
Diabetes is classified into Type 1 (insulin-dependent) and Type 2 (insulin-independent) 
diabetes. Type 1 diabetes results from loss of the insulin-producing β-cells due to an 
autoimmune destruction of the cells, leading to absolute or impaired insulin deficiency and 
the life-long need of exogeneous insulin [188]. Although Type 1 diabetes to a certain degree 
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can be controlled with exogenous insulin, the current administration methods including 
insulin injections, pumps and inhaled insulin [189] do not prevent hypo- and hyperglycemic 
fluctuations. As a result, there is a risk of acute complications like hypoglycemia and 
ketoacidosis as well as secondary complications like cardiovascular diseases, stroke, kidney 
failure, blindness, neuropathy, ulcerations, amputations and premature death [185, 190]. This 
has prompted the search for a diabetes “cure” [27].  
 
Islet transplantation 
To date, whole pancreas transplantation or transplantation of islets of Langerhans from 
deceased human donors is the only treatment for Type 1 diabetes that can induce an insulin-
independent normoglycemic state. Whole pancreas transplantation, however, requires major 
surgery and lifelong immunosuppression. Hence, most pancreas transplantations are done in 
diabetic patients with severe late-stage complications, undergoing simultaneous kidney 
transplantation. As a result, pancreas transplantation is not available to the vast majority of 
diabetic patients [27, 191].  
Islet transplantation, on the other hand, is much less invasive where functional islets, isolated 
from the pancreas of cadaveric donors, are injected into the portal vein. Before the year 2000, 
few centers performing islet transplantation achieved high rates of sustainable insulin 
independence after this procedure among patients with Type 1 diabetes. In 2000, Shapiro et 
al. [192] reported up to a year of follow-up in seven patients treated with steroid-free 
immunosuppressive therapy combined with infusion of an adequate mass of freshly prepared 
islets from two or more pancreases. In all seven patients, insulin independence was achieved 
and the treatment became known as the Edmonton protocol [193]. In spite of the high success 
rate, the most recent update [193] shows that insulin independence is usually not sustainable, 
with only 10% of patients maintaining insulin independence 5 years after transplantation, and 
many patients still suffer from immunosuppressive-related events.  
 
Hence, immunoisolation of insulin-producing cells still remains the most promising solution 
for a cure of Type 1 diabetes. The principle of microencapsulation of islets of Langerhans in 
alginate-polycation microcapsules has been widely studied by numerous research groups 
since it was first introduced by Lim and Sun in 1980 [34]. Allotransplantation has been shown 
to work routinely in diabetic rodents and in a limited number of large animals [194]. Recently, 
the first allotransplantations in humans with encapsulated pancreatic islets without 
immunosuppression were successfully performed [195]. Xenografts have also been shown to 
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reverse diabetes in rodents [196, 197] and non-human primates [198]. A Phase I/II clinical 
trial using neonatal pig islets encapsulated in alginate microcapsules without 
immunosuppression is currently ongoing [199, 200]. 
 
A more recent approach has been to omit the polycation layer using simple Ca- or Ba-alginate 
beads. This has given promising results in allotransplantation as well as in some 
xenotransplantation studies in animals [174, 175, 201-206]. 
 
Overcoming the limited islet supply 
Donor islets are extremely scarce relative to potential demand, presenting an impending 
problem which must be overcome if immobilized islets are to become a widely applied 
treatment. Xenotransplantation, regeneration therapy (generation of pancreatic β-cells from 
pre-existing β-cells or from stem cells) and development of insulin-producing cell-lines are all 
methods that are being extensively studied to overcome this problem [27, 207, 208].  
Although many species have been evaluated as potential islet donors, the pig has been 
considered the best suited, primarily due to the similarity of the porcine insulin to human 
insulin [185]. The major barriers for using xenografts are the risks of cross-species infections 
in addition to ethical aspects [27, 209, 210]. While the development of relatively non-toxic 
immunosuppressive or tolerance-inducing regimens will be required to justify clinical trials 
using pig organs, recent advances in the understanding of the biology of xenograft rejection 
and zoonotic infections, and the generation of α1,3-gal-deficient pigs have moved this 
approach closer to clinical application [211].  
The use of insulin-producing cell lines may still not be as efficient as using intact islets 
because of the intricate intra-islet relationship between the cells that govern the overall 
glucose homeostasis in the body [27]. In addition, the control of growth remains a major 
obstacle. Despite the great effort and resources put into research in the field, expansion of 
islets or development of β-cells from stem cells is still in very early experimental phase and 
many questions and problems still remain unsolved.  
 
In addition to immunoisolation, recent progress in the induction of donor specific tolerance 
[19, 27] and the development of pancreatic β-cells from human stem cells [207] gives hope 
for transplantation without immunosuppression. However, as diabetes is an autoimmune 
disease, the need for protection of the cells from the immune system may still be needed in 
order to avoid immune reaction to the insulin-producing β-cells.  
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1.6 Capsule properties 
Although many animal studies have given promising results, the successful use of 
alginate/polycation capsules as carriers for insulin producing cells in vivo has been hampered 
by the capsules' bioincompatibility and mechanical instability. The major hurdles have been 
their sensitivity to calcium sequestrants and non-gelling ions such as sodium, the osmotic 
swelling under physiological conditions, the high porosity and wide pore size distribution, and 
the presence of uncoated polycations which are the major contributors to fibrotic reaction 
towards the capsule. All in all, these shortcomings make controlled insulin release difficult.   
To overcome some of these problems it is crucial to realize some of the limitations due to the 
nature of the alginate molecule itself as a biodegradable polydisperse material and to the 
nature of the gel as a reversible ionic network. To date, it has been difficult to find an ideal 
alginate that fulfils the multitude of requirements as an immobilization matrix for islet cells. 
However, alginate gel beads should ideally be characterized by [4, 180, 212]:  
1) High mechanical and chemical stability; 2) Controllable swelling properties; 3) Low 
content of toxic, pyrogenic and immunogenic contaminants and 4) Defined pore size and a 
narrow pore size distribution.  
 
1.6.1 Stability and swelling  
Ca-alginate beads tend to swell and dissolve at physiological conditions. The swelling is 
caused by the gel network sensitivity towards chelating compounds such as phosphate, citrate 
and lactate, or non-gelling cations such as sodium and magnesium. Swelling and dissolution 
of the gel network represents a potential serious problem in immunoisolation systems. First of 
all, swelling leads to increased porosity and the loss of control of pore size. Secondly, 
disruption of the gel results in exposure of the transplanted cells.   
 
Ionically linked alginate gels can be looked upon as osmotic swelling systems where the gel 
surface functions as a semi-permeable membrane through which the polymer molecules 
cannot diffuse out. The swelling force resulting from the presence of the fixed charges on 
alginate may be identified with the osmotic pressure across the semi-permeable membrane in 
a typical Donnan equilibrium [97]. Due to the attracting power of the fixed charges in the 
alginate network and requirements of electroneutrality, the concentration of mobile ions will 
always be greater in the gel than outside. Consequently, the osmotic pressure of the solution 
inside will exceed that of the external solution.  
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Generally, the osmotic contribution to swelling of an ionic network is composed of two terms; 
The polymer-solvent mixing term (Δμmix) and the chemical potential difference of water due 
to uneven distribution of ions between the inside and the outside of the gel, (Δμion). In an 
alginate gel the ionic term is dominating and the contribution comes from the non-
cooperatively bound counter ions. The swelling is opposed by the physical crosslinks, leading 
to an elastic network retraction force [97, 108, 213, 214] (Figure 12). 
 
 
Figure 12. Factors influencing the swelling of a gel network. 
 
At equilibrium the volume of the gel is stabilized by the elastic forces of the gel network:   
 
Δμmix  + Δμion + Δμela = 0                    (1-7) 
 
The polymer-solvent mixing term will mostly depend on the interactions between the polymer 
and the solvent (hydration of the polymer) [214], whereas the elastic term is highly dependent 
on the number and strength of the crosslinks in the polymer network. The ionic term will 
depend on the salt concentration outside the gel, the valence of the counter ion and the 
effective charge density of the polymer [213].  
 
The swelling of Ca-alginate gels under physiological conditions depends on the alginate 
composition and polymer concentration. Calcium ions will be exchanged with non-gelling 
sodium ions, dissolving the junctions in the network, consequently reducing the elastic term. 
At the same time the number of dissociable counter ions increases as - given the different 
valence of Ca2+ and Na+ - each calcium ion will be replaced with two sodium ions (enhancing 
Elasticity of the network
∆µel
Osmotic pressure due to
polymer-solvent mixing
∆µmix
Osmotic pressure
due to free ions
∆µion
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the ionic term). Both these effects contribute to swelling of the hydrogel network. Swelling 
can be reduced by using alginate with a high content of long guluronic acid blocks [91, 168] 
or by replacing calcium ions with stronger binding ions such as Sr2+ or Ba2+ [39, 168, 215].  
 
A polyanion-polycation complex membrane will stabilize against swelling both by increasing 
the elastic forces and by partly decharging the polymer network [216]. For small capsules 
where the surface to volume ratio is high this decharging can be so effective that the capsules 
collapse [151]. Increasing concentration and exposure time to poly(L-lysine) and decreasing 
molecular weight of the polypeptide increases the stability of capsules. In addition, poly(L-
lysine) binds to a higher extent to high-M alginate than to high-G alginate, and higher 
concentration of polymer at the surface will enhance the binding of polycations to alginate 
beads [6, 157, 168, 216, 217]. 
 
Another approach for stabilizing alginate gels is by covalent crosslinking. Various techniques 
have been applied, including direct crosslinking of the carboxyl groups [218] or covalent 
grafting of alginate with synthetic polymers [219]. A combination of covalent and ionic 
crosslinking has also been proposed [220] as well as covalent crosslinking of the polylysine to 
the alginate [221]. A drawback using some of these methods has been the lack of selectivity 
characterizing chemical modifications that generally occur both on guluronic acid (G) and 
mannuronic acid (M) residues, hampering the ability of the modified alginate to form 
instantaneous calcium gels. A new approach has recently shown to be able to overcome this 
limit by using a combination of mannuronan C5-epimerases and chemical modification [222]. 
 
1.6.2 Biocompatibility 
The two major components of an immunoisolation device are the transplanted cells and the 
immobilization material. The interconnection between the host responses to the capsule 
material and the transplanted cells determines the biocompatibility of the device. The 
inflammatory response towards the capsule material itself can impact the immune response 
towards transplanted cells and vice versa [10, 166]. Moreover, it is important to realize that 
the concept of a biocompatible material is not synonymous with the material being inert, as 
implantation of any material to the body evokes a certain immune reaction [24].  
The biocompatibility of the capsule material will depend on many factors, such as chemical 
composition, surface charge, porosity, surface roughness, implant site and shape [10]. 
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Leakage of capsule material out of the device may also affect its biocompatibility [140]. A 
central consequence of the inflammatory response to the capsule material is the activation of 
macrophages resulting in the release of cytokines, growth factors, proteolytic enzymes, and 
reactive oxygen and nitrogen intermediates. The inflammatory response eventually leads to 
formation of a fibrotic tissue on the capsule surface composed largely of collagen, 
macrophages, fibroblasts and few, if any, capillaries [10, 22, 223, 224]. Some speculate that 
overgrowth can increase vascularization and thereby increase the in vivo function. However, 
the general view is that fibrosis should be minimized as it has been demonstrated that islets in 
capsules without overgrowth provide better functionality [212, 225]. A thick fibrous tissue 
surrounding the implanted microcapsule prevents proper nutrient and oxygen diffusion to the 
encapsulated cells, quickly leading to massive loss of cell viability and functionality [10, 22], 
which unfortunately has been a repeating trend in animal studies with encapsulated islets 
[226, 227].  
 
Biocompatibility of alginate 
Although alginates fulfil the requirements as additives in food and pharmaceuticals, as a 
natural material they contain various amount of other biological compounds such as 
endotoxins (LPS), proteins, complex polysaccharides and polyphenols which might be 
harmful to sensitive cells, or have impact on the biocompatibility of the capsules [228, 229]. 
In the recent years, there has been much focus on the necessity of purification of the alginate 
material with regard to biocompatibility concerns [6, 39, 229] as some authors have claimed 
that alginate purity is the main factor determining the biocompatibility [40, 230]. Several 
procedures for purifying alginates are found in the literature [228, 229, 231], and ultrapure 
grades of alginates approved for implantation purposes are available commercially [232]. 
However, evidence of overgrowth on capsules of highly purified alginate [233] suggests that 
there probably are additional factors influencing biocompatibility. Presence of residual 
contaminants in ultrapure commercial samples has very recently been revealed [229, 231], 
thus illustrating the difficulties connected with evaluations of possible bioincompatibility 
causes.  
It is controversially under discussion whether alginate with low or high content of G is 
advantageous, or if the molar mass has an impact on alginate biocompatibility. Alginates with 
a high content of M have shown to stimulate human monocytes to produce TNF-α, IL-1 and 
IL-6 [140]. The cytokine-inducing effect [234] and fibrosis [235] has shown to increase with 
increasing molecular weight. Others report that the biocompatibility is independent of 
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mannuronic/guluronic acid ratio and molar mass of the alginate [236]. Due to the low 
cytokine response, alginates with a guluronic acid content higher than 50% has been 
recommended for transplantation purposes [237]. In a diabetic patient transplanted with 
encapsulated islets, antibodies against alginate were found 1-2 weeks after transplantation. 
The antibody response was, however, found to be transient [237].  
As calcium does not form crosslinks with M-blocks, low MW high-M material has been 
predicted to leak out of the capsules [86] and evoke an immune response [140]. This has been, 
at least partly, linked to the β(1→4) glycosidic linkages between the mannuronic residues 
since also other homopolymeric diequatorial polyuronates, like D-glucuronic acid (C6-
oxidized cellulose), also exhibit this feature [4].  
 
Biocompatibility of alginate/polycation microcapsules 
Fibrosis to encapsulated islets has in general been attributed to exposure of donor cell through 
capsule rupture or protruding cells or to cell material leaking out of the capsule [6, 166, 238]. 
Nevertheless, empty capsules are routinely found with fibrotic overgrowth [164, 165, 224, 
239, 240].  
The fibrotic overgrowth on empty alginate/polylysine capsules has in numerous studies been 
connected to the poly(L-lysine) [164, 216, 233, 236, 241, 242]. Alginate/polylysine capsules 
have been shown to activate complement [243] and macrophages [240, 244] and the 
polypeptide has been reported to be toxic to numerous cell lines [241]. Since poly(L-lysine) is 
a positively charged molecule it also favors the adherence of cells which tend to have a netto 
negative surface charge [212]. Reducing the amount of poly(L-lysine) improves the 
biocompatibility of the capsules [241]. The importance of alginate composition on 
biocompatibility of alginate/polylysine capsules is controversial. Some investigators have 
reported increased fibrosis with high-M alginates [164, 240, 245], whereas others report that 
high-G alginates induce fibrosis to a larger extent [242, 246, 247]. It has been suggested that 
these differences may be due to differences in alginate purity [248].  
 
Although some believe that poly(L-lysine) polycation has a low probability of success as a 
result of its poor biocompatibility [237], others have obtained promising in vivo results 
replacing PLL with poly(L-ornithine) [195] or poly(methylene-co-guanidine) hydrochloride 
[38]. However, this topic is still debatable as others have shown that alginate/polyornithine 
capsules induce fibrosis to a higher degree compared to alginate/polylysine capsules [227, 
249].  
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The importance of coating the polycation to shield excess negative charges has also been 
acknowledged [164]. Low molecular weight alginate seems to be favorable in binding to the 
polycation [157] and enzymatically modified alginate using the AlgE4 epimerase has been 
shown to increase the biocompatibility [216]. A more efficient coating has been promoted 
using polyacrylic acid [165]. In connection with the latter study and other studies [40, 250], 
the surface roughness of capsules was thought to be an important factor for biocompatibility 
as rough surfaces present suitable targets for the attachment and growth of anchor-dependent 
cells like monocytes, macrophages and fibroblasts. Surface charge has likewise been 
suggested to play a role in biocompatibility [251, 252]. The influence of implantation site 
[166, 202, 253] and host species [242, 254] on the biocompatibility of alginate capsules has 
also been reported.   
 
All in all, although intensely studied for more than a decade, no general agreement exists 
concerning alginate’s biocompatibility in the scientific community yet. 
 
1.6.3 Permeability  
Permeability is a major factor determining the functionality of alginate capsules, particularly 
for cell transplantation applications. Maintenance of cell viability and function requires both 
protection against the host immune system and sufficient supply of nutrients and oxygen. At 
the same time, the necessity of almost unrestricted diffusion of catabolic products like insulin 
out of the capsule should be met. Preventing immune cells from entering the capsule 
membrane is a relatively easy challenge to meet. However, these cells can secrete low 
molecular weight molecules that may be deleterious to cells. The challenges of keeping these 
outside the capsule membrane are more serious, since many of these components are smaller 
or similar in size to essential cell nutrients or products [21]. Hence, it is a difficult, if not 
impossible task to design a capsule meeting all these permeability requirements. Nevertheless, 
certain molecules of the immune system, like cytokines, immunoglobulins and elements of 
the complement system should ideally be completely, or at least partly, prevented from 
entering the capsule membrane to avoid or minimize the host reaction to the implant.   
 
The permeability of capsules is determined by both the molecular weight cut-off (size-based 
exclusion) and the rate of diffusion of the molecules.  
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The driving force in a diffusion process is the chemical potential gradient (or concentration 
gradient) of molecules in the solution. The movement results from random motion of 
particles, causing them to move from an area of high concentration to an area of low 
concentration [110]. In hydrogels, the diffusion of solutes is determined by many factors 
[255]. The first is the obstruction caused by the presence of impenetrable slowly moving 
polymer chains that increase the path length for diffusion. The second process is the 
hydrodynamic drag on the moving solute at the polymer-solvent interface. The third is the 
different extend of heterogeneity of the membrane material with fluctuation of diffusion 
properties across the membrane material. Finally, residual charges, presence of counter ions, 
hydrogen bonds, polar and hydrophobic interactions of the membrane material will affect the 
diffusion of solute, especially essential in diffusion of biological molecules. 
Diffusion of small molecules seems to be very little affected by the alginate gel matrix. The 
diffusion of glucose and ethanol has been reported to be as high as 90% of the diffusion rate 
in water [256, 257]. The diffusion rate, however, decreases with increasing cell load [258]. 
For larger molecules such as proteins, diffusional resistance occurs, although even large 
proteins with molecular weights > 3·105 Da will leak out of the gel beads with a rate 
depending on their molecular size, shape and pH of the solution [91, 257, 259].  
Since the alginate gel matrix is negatively charged, electrostatic forces between the gel 
network and ionic substrates must also be considered. Hence, in addition to size, the diffusion 
of proteins over the alginate membrane will also depend on the total net charge of the protein 
molecule [260]. The negative charges of the alginate matrix are also responsible for the 
observed difference between protein ingress and egress. At neutral pH, most proteins are 
negatively charged and will therefore not easily diffuse into the matrix. When such proteins 
are immobilized in a gel, the repulsive forces result in an efflux that is greater than their free 
molecular diffusion rate [147]. 
 
In addition to diffusion characteristics, the molecular weight cut off (MWCO), pore-size and 
pore size distribution may be essential parameters in an immobilization system. Electron 
microscopy and inverse size exclusion chromatography has been used to study pore size and 
molecular weight cut-off of alginate gels and capsules [54, 260-263]. It has been estimated 
that the size distribution of pores in an alginate gel from L.hyp stipe (high-G alginate) is wide, 
ranging from 5-150 nm [50].  
The MWCO and the rate of diffusion of solute are obviously connected and of equal 
importance for quantification of the capsule permeability characteristics. Nevertheless, the 
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vast majority of studies only characterize the MWCO to quantify the diffusion properties. 
However, this does not adequately predict the diffusion properties of a certain solute in 
hydrogels where there are large variations in membrane chemical composition, density, 
interactions with solutes as well as non-uniformity in pore sizes [264]. 
It is important to emphasize that MWCO is determined by size and shape of the considered 
molecule rather than its molar mass. Hence, the molecular weight of a protein does not 
necessarily indicate whether it will be able to penetrate the capsule membrane or not. Rather, 
the radius of gyration (RG) gives a more direct measurement of the spatial requirements of a 
protein in solution [110] (Figure 13).  
 
Insulin
5.8 kDa
TNF-α
51 kDa
IgG
150 kDa
Transferrin
80 kDa
IL-1β
17.5 kDa  
 
Figure 13. Size comparison of some globular proteins. The radius of gyration (RG) of a globular protein is 
proportional to the cubic root of the molecular weight [110]: RG ∝ Μw1/3.  
 
Both the alginate concentration and composition will all affect the permeability of the gel. 
Increasing polymer concentration decreases the permeability [256, 260]. The highest diffusion 
rates of proteins, indicating the most open pore structure, are found in beads made from high 
G-alginates [91], in particular those containing long G-blocks [82, 94]. This has been 
explained by the stiff and static network of these gels compared to the more dynamic and 
entangled network structure of the low-G gels with their relative long elastic segments. Lastly, 
the Ca2+ concentration in the gelling solution will further influence the porosity of the Ca-
alginate gel as high concentrations of calcium will result in lateral association of junctions. 
This will leave more space in between the junction zones and thus make a more porous gel 
[155]. 
In many gel systems syneresis is considered a problem. However, for immunoisolation 
purposes, syneresis might be an advantage by creating gels with reduced porosity. Since the 
alginate concentration is inversely proportional to the volume of the beads, the linear 
dimension of the pores in the gel-network is expected to be roughly proportional to the 
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inverse cube root of the concentration of alginate provided that the alginate molecules are 
uniformly distributed throughout the gel-bead. Finally, a concentration gradient of polymer 
will have an impact on permeability, where a higher concentration at the surface of the beads 
(see section 1.6.5) may reduce the porosity at the surface [260].  
 
Ca-alginate gel beads have been shown to be permeable to immunoglobulin G (IgG, 150 kDa) 
[151, 265] and complement [266]. The high porosity of the alginate network has promoted the 
development of coating techniques, and several of the procedures for stabilizing the alginate 
gels mentioned in section 1.6.1 will also have some influence on the porosity of the gel. 
Formation of polyanion-polycation membranes with polypeptides [151, 217, 263, 265, 267] 
or chitosan [268] has been used to prevent diffusion of antibodies through the capsule mem-
brane, and the capsules can be made impermeable to TNF (51 kDa) using higher 
concentrations or exposure times in poly(L-lysine) [265, 268]. Molecules as small as insulin 
can be retained after using poly(D-lysine) as polycation [265].  
 
1.6.4 Capsule strength  
An alginate microcapsule to be used for transplantation should have sufficient mechanical 
resistance to withstand the forces, including compression and shear stress, exerted on the 
capsule in vivo. Increasing the strength and resistance of capsules will increase the durability 
of the transplant and prevent the exposure of encapsulated cells. Although it is a rather simple 
task to increase the mechanical strength of alginate gels, e.g. by increasing the guluronic acid 
content or replacing Ca2+ with stronger binding ions (see section 1.3.4), this will often 
represent drawbacks on other capsule parameters. As an example, Ca-alginate beads with the 
highest mechanical strength are generally made from alginate with a content of guluronic acid 
higher than 70% and an average G-block length of > 15 [91]. Increasing the G-content will, 
however, simultaneously lead to higher permeability [91] and a more brittle consistency 
[269].  
The required mechanical stability for capsules containing therapeutic cells depends on the 
proposed site of implantation. Lacik et al reported a few to tens of grams per capsule for 
intraperitoneal application [24]. Others have estimated a threshold of approximately 50 g per 
capsule for their general safe handling [163]. The cell load will probably influence the 
mechanical properties in a negative fashion [270] and the same will apply for capsules with a 
dissolved core [167, 168].  
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1.6.5 Polymer distribution in gel beads 
Gelling kinetics can have a dramatic effect on functional properties of alginate gels. It has 
previously been demonstrated that calcium alginate gels prepared by dialysis often exhibit a 
concentration inhomogeneity characterized by a high concentration of polymer at the calcium-
alginate interface and decreasing concentration towards the center of the gel (Figure 14) [148, 
271, 272]. This may be a preferred structure in microcapsules due to lower porosity at the 
surface [260] and higher resistance against swelling [168]. The inhomogeneity has been 
explained as a result of a rapid and virtually irreversible site binding of divalent metal ions as 
they diffuse into an alginate solution, producing an inwardly moving gelling zone. The 
steepness of the gradient has been assumed to be governed by the relative diffusion rate 
between calcium ions and polymer molecules. The diffusion of alginate towards the gelling 
zone, leading to a depletion of alginate in the center (Figure 6 and 14), is faster than the self-
diffusion of the macromolecules due to the coupled diffusion of the sodium ions.  
The polymer gradient of the gel can thus be controlled by a careful selection of the gelling 
conditions. In general, low molecular weight alginate, low concentration of gelling ions and 
absence of non-gelling ions give the highest inhomogeneity [271].  
Inhomogeneity can be suppressed by letting gel formation take place in the presence of non-
gelling salt such as sodium chloride, a salt that is frequently used as osmolyte when handling 
animal cells. The presence of sodium ions influences the gelling process by disrupting the 
diffusion of sodium alginate towards the gelling zone [271]. The result will be a capsule with 
a homogenous distribution of alginate molecules in the gel core (Figure 14). Thus by 
replacing sodium chloride as osmolyte with a neutral compound such as mannitol or glycerol 
inhomogeneous gels are obtained.  
 
 
 
 
 
 
 
Figure 14. Schematic illustration of polymer gradients in alginate 
gels: Homogeneous (left) and inhomogeneous (right) gel beads. 
Equatorial sections of the capsules are shown.  
Gel core 
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1.6.6 Size  
Bead size is an additional important parameter of alginate gel beads and capsules in the 
immunoisolation of islets. The use of smaller capsules increases the surface to volume ratio, 
leading to improved insulin kinetics [273] and enhanced oxygen [21] and nutrition supply 
[263]. As the volume of a sphere has a cubic relation with its diameter, size reduction has a 
dramatic effect on transplantation volume. This also raises potential for new implantation sites 
[150, 263]  
However, the appropriate size will often be a compromise. Due to their larger surface to 
volume ratio, smaller capsules are more prone to osmotic stress and subsequent swelling than 
larger capsules [151, 212]. When very small beads are coated with polycation, the surface 
tends to collapse due to decharging of the network [151]. The bead itself must also be large 
enough to cover the islets which can range in size from 50-400 μm. From a practical point of 
view, larger beads may also be easier to handle. In some studies, increasing bead size has 
shown to increase the biocompatibility [204, 205], whereas other studies have shown the 
opposite trend [274]. 
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2 AIMS 
The overall scope of these studies has been to enhance the functional properties of 
alginate gels intended for use as immunoisolating material for living cells, with focus 
on islets of Langerhans.  
 
The specific aims were to: 
 
1) Study alginate capsules using confocal laser scanning microscopy in order to 
elucidate how various gelling ions, encapsulation procedures and gelling 
kinetics affect the macroscopic structure of capsules. 
 
2) Increase the stability and reduce permeability of the alginate gel, with the aim 
to reduce or omit the polycation layer, thereby increasing the biocompatibility 
and functionality of the microcapsules. The goal was to evaluate two different 
approaches: 
 
i. Exchange Ca2+ as gelling ion with ions of higher affinity to alginate 
ii. Enzymatic modification of alginate   
 
3) Illuminate the role of alternating sequences in alginate gel formation in order 
to get a better understanding of the manipulations that can be done to enhance 
capsule properties by enzymatic modification.  
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3 SUMMARY OF PAPERS 
Paper 1 
In Paper 1 we evaluated confocal laser scanning microscopy (CLSM) as a tool for 
investigating the distribution of polymers in various capsules and beads using 
fluorescent probes covalently linked to alginate and poly(L-lysine) (PLL). CLSM was 
shown to provide a novel and simple method for studying the distribution of 
fluorescent-labeled molecules in an optical slice of capsules. 
CLSM studies of Ca-alginate gel beads revealed a more inhomogeneous distribution 
of alginate in beads formed in the absence of non-gelling ions. In the formation of 
alginate/PLL capsules the polymer gradient was destabilized due to the presence of 
non-gelling ions in the washing step and in the PLL solution. The inhomogeneous 
structure of Ca-alginate gels was preserved upon removing non-gelling ions (Na+) 
from these solutions. By exchanging Ca2+ with lower concentrations of Ba2+, 
extremely inhomogeneous gel beads were formed that preserved their structure during 
the washing and exposure to PLL in saline.  
PLL was shown to bind at the very surface of the alginate core, forming a shell-like 
membrane. The thickness of the PLL-layer increased by approximately 100% during 
two weeks of storage, but no further increase was seen after two years of storage. The 
coating alginate was shown to overlap the PLL layer. CLSM imaging did however not 
give information about differences in binding among coating alginates of different 
composition.  
 
Paper 2 
In this study, we wanted to characterize the effect of different alginates and 
crosslinking ions on important microcapsule properties. Great effects were seen on the 
selection of type of gelling ions on both the swelling properties and gel strength of 
high-G alginate and high-M alginate. Both the dimensional stability and gel strength 
increased for high-G alginate gels when exchanging the traditional Ca2+ ions with 
Ba2+. The use of Ba2+ decreased the size of alginate beads and reduced the 
permeability to immunoglobulin G. Strontium gave gels with characteristics lying 
between calcium and barium. Interestingly, high-M alginate showed an opposite 
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behavior in combination with barium and strontium as these beads were larger than 
beads of calcium-alginate and tended to swell more, also resulting in increased 
permeability. The recent availability of pure polyM and polyMG samples made ion 
binding studies on these samples possible. Circular dichroism studies revealed that 
different block structures in the alginate bind the ions to a different extent. More 
specifically, Ca2+ was found to bind to G- and MG-blocks, Ba2+ to G- and M-blocks, 
and Sr2+ to G-blocks solely.  
 
Paper 3 
In Paper 3 we investigated how capsule properties such as stability and permeability 
were affected by increasing the number of alternating blocks in the alginate chains 
using the AlgE4 epimerase. Inhomogeneous calcium-alginate gel beads were made 
with original and AlgE4-epimerized alginates of different origin. The epimerized 
alginates formed initially smaller alginate gels that showed increased resistance to 
osmotic swelling compared with the original unmodified alginate samples. The 
permeability, measured as diffusion of immunoglobulin G (IgG) into Ca/Ba-alginate 
gel beads, was reduced by epimerization and further reduced by addition of poly(L-
lysine) (PLL). The osmotic stability of alginate/poly(D-lysine)/alginate capsules was 
enhanced by the use of epimerized alginate. Indeed, stable capsules with low 
permeability to tumor necrosis factor (TNF) could be made with low PDL exposures. 
Finally, alginate with an alternating structure was found to interact more strongly with 
the alginate-PLL capsule than did alginate with a high content of M blocks or G 
blocks or than an alginate consisting mainly of M. 
 
Paper 4 
The striking effects observed in Paper 3, upon introducing alternating blocks into the 
alginate backbone of seaweed alginate, lead us to investigate the specific role of the 
alternating sequences in the Ca-alginate gel network. To date, the general assumption 
has been that alternating sequences do not contribute to gelling per se, but rather 
contribute to the gels overall functionality by reducing the stiffness of the 
polysaccharide chain. In Paper 4 we show that G blocks in fact are not the only 
sequences involved in junction formation, and propose the direct involvement of long 
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alternating sequences in the gel network. The new hypothesis was based on 
experimental data from alginates enzymatically enriched in alternating sequences. 
More specifically, results from 1H NMR and circular dichroism studies indicated for 
the first time the formation of mixed junctions between G and MG blocks. This was 
supported by the analysis of the Young’s modulus of hydrogels from natural and 
epimerized samples obtained at low calcium concentrations. Furthermore, the 
“zipping” of long alternating sequences in secondary MG/MG junctions was 
suggested to account for the shrinking (syneresis) of alginate gels in view of its 
dependence on the length of the MG blocks. As a consequence, a partial network 
collapse, macroscopically revealed by a decrease in the Young’s modulus, occurred as 
the calcium concentration in the gel was increased.  
The effect of the presence of secondary MG/MG junctions on the viscoelastic 
properties of the gels was investigated by measuring their creep compliance, which 
suggested an ion mediated mechanism preventing slipping within the network of the 
gel.  
 
Paper 5 
Here we report the application of a set of mannuronan C-5 epimerases for the 
preparation of novel alginates with highly improved functional properties essential for 
numerous applications as gel matrices. The final polymers are designed to optimize 
calcium binding and to enhance flexibility in the interjunction regions.  
The structural modification of alginate is based on a two-step process starting with a 
homopolymeric mannuronan which was epimerized with the C-5 epimerase AlgE4, 
converting the entire polysaccharide backbone into strictly polyalternating sequences. 
The resulting polyMG alginate was further processed by a second C-5 epimerase, 
AlgE1, converting M residues interspersed by G or by condensing G blocks. Thus the 
most important structural features distinguishing these engineered polymers from 
seaweed or bacterial alginates are the absence of M blocks and the high content of 
long G blocks. The total guluronic acid content in the product was controlled by 
epimerization time, ending up with various samples of different composition.  
Ca-alginate gels of the engineered alginates were found to be more elastic and 
compact, less permeable, and extremely stable under physiological conditions, 
offering significant advantages over native alginates. Moreover, the properties were 
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highly dependent on the total G content. The observed effects were believed to be a 
result of the combination of the very strong binding of Ca2+ to both long GG and MG 
blocks. This study hence showed that by controlling alginate nanostructure its 
macroscopic properties can be highly controlled.  
 
Paper 6 
In Paper 6 we further investigated the mechanical properties of enzymatically 
modified alginates. In particular, differences in the mechanical properties of alginates 
epimerized with AlgE4, introducing alternating structure, and two G-block forming 
epimerases (AlgE1 and AlgE6) were studied. Both well-characterized algal polymers 
and pure mannuronan were epimerized with the bacterial enzymes.  
Composition and sequential structure of controls and epimerized alginates were 
analyzed by 1H-NMR spectroscopy. Mechanical properties of Ca-alginate gels were 
further examined by uniaxial compression measurements giving Young’s modulus, 
syneresis, rupture strength and elasticity of the gels. Both Ca-saturated and Ca-limited 
gels were examined. 
The G-block forming epimerases were found to introduce long homologous G-blocks, 
indicating a processive mode of action. Differences in epimerization pattern 
depending on the alginate backbone were also shown. The mechanical properties of 
Ca-alginate gels were highly dependent on the length of both GG and MG sequences.  
As expected, Young’s modulus (E) increased with increasing amount of guluronic 
acid in Ca-saturated samples. Epimerization of seaweed alginates led in all cases to 
increased E compared to control, samples epimerized with AlgE4 resulting in highest 
gel strength values.  
Surprisingly, a pure polyalternating sample gave gels of extremely high rupture 
strength compared to all other samples. However, increasing the amount of G in the 
form of G-blocks by only 2% using AlgE1, the rupture strength was reduced by over 
60%. The high rupture strength of the polyMG sample was explained by a possible 
mechanism involving “sliding” of MG-MG junctions.  
Results from this work led to better understanding of the relationships between 
polymer structure and mechanical properties in alginates and the role of long 
alternating sequences in this respect. Further, the results highlighted the importance of 
SUMMARY OF PAPERS 
 50
choosing an appropriate method to describe the rheological properties of the gel, 
depending on its intended application.  
 
. 
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4 GENERAL DISCUSSION 
4.1 What determines the final capsule properties? 
A large portion of the work in this thesis has been attributed to relating alginate 
composition to the final properties of alginate gels in a search for a better suited 
capsule for immunoisolation purposes. It was found that the final gel properties 
depend on many factors, such as the choice of alginate material (Paper 1, 2, 3, 5 and 
6), choice of gelling ion (Paper 1, 2 and 3) and method of preparation (Paper 1). 
 
4.1.1 Choice of alginate material  
Alginate composition and sequence has in numerous studies shown to be a major 
determinant for the final gel properties. Alginates containing high amounts of 
mannuronic acid and alternating sequences will form compact, but softer gels as 
compared to materials containing long G-block sequences which form a more open 
and stiff gel network [91, 269]. Present and previous studies have shown that the 
composition also affects both the binding of alginate to divalent ions (Paper 2) and the 
binding of polycations to the alginate gel (Paper 1 and 3).  
A controversy is that alginates of high mechanical stability give the most permeable 
gels [91] while the initially least permeable gels have a lower stability. Hence, 
epimerization of high-G alginates with AlgE4, allowing a denser structure by 
increased syneresis and further stabilization due to enhanced calcium binding (Paper 
3-5) might combine these two properties which both are important in ensuring good 
immune protection. The steeper polymer concentration gradient in gel beads of 
epimerized alginates (Paper 5) contributing to lower permeability is also preserved to 
a larger degree compared to controls (unpublished data).  
King and coworkers [216] showed that AlgE4 epimerization of a high-G seaweed 
alginate was not sufficient to completely prevent the swelling of alginate beads. In 
contrast, extremely stable gels could be formed by a two-step epimerization of 
mannuronan (Paper 5). Further, this demonstrated the possibility of fine tuning of the 
hydrogel properties by using molecular engineering to design alginates with the ideal 
composition for a given application (Paper 5 and 6). Lastly, as algal alginates show 
great compositional and structural heterogeneity, the use of epimerases as tools in 
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polysaccharide engineering can provide well-defined alginates with a much more 
homogenous composition (Paper 5), better suited in pharmaceutical and biomedical 
applications.  
 
4.1.2 Choice of gelling ion  
The alginate composition was in Paper 2 also shown to be an essential factor for 
increased stabilization of the gel network by means of barium and strontium ions. 
Barium was shown to bind to G-blocks and M-blocks, while the binding to alternating 
sequences was limited. Strontium, on the other hand, bound to G-blocks solely. This 
will have a large impact on the final functionality of the capsules, further illustrated 
by the low stability of both Ba-alginate and Sr-alginate gels containing high portions 
of MG sequences (Paper 2 and unpublished data).  
When replacing calcium for barium in order to enhance stability, the potential toxicity 
of barium ions must be taken into consideration. Thus, the concentration of barium 
should be minimized and the alginate material chosen according to the highest 
possible binding. In Paper 2 and 3 we demonstrated that low concentrations of barium 
(Ca:Ba proportions of 50:1) were enough to stabilize the gel network considerably 
and thus higher barium concentrations would be unnecessary for this purpose. This 
may be of importance as many researches have started to replace the 
alginate/polycation capsule with a pure Ba-alginate bead, sometimes using 
concentrations as high as 25 mM Ba2+ [176]. This leaves barium as the only counter 
ion, also for alginate chains not bound in junctions, and these free barium ions will be 
easily exchanged with sodium in vivo. Thu et al have shown that when using low 
amounts of barium the leakage of Ba2+ ions from alginate/polylysine capsules of high-
G alginate materials is very limited [168]. Ongoing in vitro studies on Ba-alginate and 
Ba/Ca-alginate beads show that the long-term leakage of barium is up to 25 times 
higher from a pure Ba-alginate bead compared to beads of Ba/Ca alginate 
(unpublished data).  
 
4.1.3 Method of preparation 
Alginate gels prepared by dialysis have earlier been shown to exhibit a concentration 
inhomogeneity where the polymer concentration is considerably lower in the center of 
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the gel than at the surface [148, 271, 272]. Further, the steepness of the concentration 
gradient has been shown to be dependent on the method of preparation, in particular 
on the concentration of gelling ions and the presence of non-gelling ions (Na+). In 
Paper 1 and 2 we were able to study this phenomenon by means of fluorescence 
labeled alginate and confocal laser scanning microscopy. The concentration of gelling 
ions was shown to be of greater importance than their affinity upon inducing a 
concentration gradient (Paper 2). However, ions of higher affinity were less prone to 
destabilization of the gel network during washing in saline (Paper 1).  
Further evidence for the importance of the method of preparation are results from 
measurements of syneresis showing that alginate gels made first in the presence of 
calcium and then dialyzed against Ba2+ or Sr2+ showed a higher degree of syneresis 
compared to gels made in the presence of mixtures of Ba/Ca or Sr/Ca (unpublished 
results). This observed hysteresis adds to the knowledge that alginate gels are of non-
equilibrium nature [90, 102], their properties being dependent on the history of 
formation in addition to the environment to which the gels are placed.  
 
An obvious observation and important message which can be drawn from the above 
mentioned papers is that changing a single capsule parameter will have effects on 
many of the other parameters determining the final functionality of the gel. 
Unfortunately, the connections are not always straightforward. This is one of the 
reasons for the major discrepancies found among the different scientific results in the 
field of alginate capsule research. Hence, when choosing a system for cell 
encapsulation, all the above mentioned factors need to be taken into consideration. 
 
4.2 Role of alternating sequences on alginate gel properties 
The recent availability of the C-5 epimerases has allowed for an extremely efficient 
tuning of both composition and physicochemical properties of the alginate. In 
particular, the epimerase AlgE4 which enables the conversion of M blocks into 
alternating sequences has provided new alginates with interesting properties. Results 
from Papers 3, 4, 5 and 6 all illustrate this by the striking effects seen upon 
introducing MG blocks into the alginate chains. The higher degree of both syneresis, 
stability and elastic modulus observed for these samples were in previous studies [92, 
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93] and in Paper 3 attributed to the intrinsically higher flexibility of MG compared to 
GG and MM diads [56] solely.  
Although the calcium binding ability of alternating sequences has been suggested [79, 
102, 275], the undoubtedly lower affinity toward the cation has confined MG blocks 
to a mere part of the elastically active chain in the gel network, without any direct 
involvement in the formation of the junction zones. In Paper 2 and 4 we showed that a 
pure alternating sample in fact could form a solid Ca-alginate gel. Further, in Paper 4 
we hypothesized the direct involvement of long alternating sequences in the formation 
of a gel network by means of both pure MG-MG and mixed MG-GG junctions. 
Examination of the rheological properties of epimerized samples containing long 
polyalternating sequences (Paper 6) further suggested the “sliding” of junctions upon 
deformation as opposed to the unwinding of the junctions, explaining the strikingly 
high rupture strength of a polyalternating sample. In sum, the availability of 
epimerases has allowed us to get a better understanding of the structure-function 
relationships of alginate gels. 
The binding of alternating sequences to other divalent ions (Paper 2) has also given us 
new insight into the gel properties upon replacing Ca2+ with ions of higher affinity to 
alginate (Ba2+ and Sr2+). The studies revealed that Ba2+ and Sr2+ in fact did not bind to 
alternating structures to the same extent as Ca2+, probably related to their different 
ionic radius (increasing in the order Ca2+ < Sr2+ < Ba2+) [276] and the size of cavities 
formed by MG diads. The different diad pairs presumably exhibit specific molecular 
geometry making them variously suitable to bind the different divalent cations [76, 
277]. 
While many features of the alternating sequences have been elucidated in present 
work, some questions still remain unanswered. The temperature dependence on 
Young’s modulus (E) for a polyalternating sample would, for instance, possibly help 
determine whether the gel network of a polyalternating sample is of an enthalpic or 
entropic (rubber like) nature. 
The role of alternating sequences on the different functional properties of alginate 
gels, as interpret from the results from Paper 3-6, can be summarized as shown in 
Table 1. 
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Table 1. Summary of the role of alternating sequences on functional properties of alginate gels  
Functional property 
Effect of increasing MG 
sequences 
Possible reason for the 
observed effect 
Syneresis ↑  Increased 
• Partial network collapse 
due to zipping of long 
alternating sequences  
• More flexible junctions 
allowing for more 
crosslinks to form 
Porosity ↓  Reduced 
• More compact polymer gel 
network due to syneresis 
• Less swelling  
Stability against swelling  ↑ Increased 
• More compact network 
leading to increased 
number of crosslinks and 
lateral association 
• Reduced number of mobile 
counter ions 
• Possible cooperative 
binding of Ca2+ to MG 
sequences 
Inhomogeneous polymer 
distribution 
↑  Increased • Reduced size due to higher 
degree of syneresis 
Rupture strength ↑  Increased 
• Increased polymer 
concentration due to high 
degree of syneresis 
• Increased number of 
junctions which need to be 
unwound before rupture 
Young’s modulus ↑  Increased 
• Elongating alternating 
sequences leads to 
formation of new MG-MG 
and mixed MG-GG 
junctions 
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4.3 Capsules or beads?  
One of the mail goals of Paper 1-3 and Paper 5 was to optimize the stability of the 
alginate gel core in order to be able to reduce or even omit the polycation layer, which 
in general is believed to be the main contributor to the bioincompatibility of capsules 
in vivo. As the polycation is added to reduce permeability and increase the stability of 
capsules (Paper 1 and 3), omitting the polycation layer implies making alginate gel 
beads with lower permeability and improved stability.    
 
4.3.1 Permeability 
Many groups have shown that a simple Ca-alginate gel bead protects from direct cell-
to-cell contact [201, 225, 266, 278, 279]. However, smaller molecules have been 
shown to traverse the membrane to various extents. These include cytokines as well as 
preformed antibodies or antibodies to antigens which have leaked across the barrier.  
In spite of all the research on the field, the exact permeability requirements for 
complete immune protection are still not known as there are large discrepancies 
between the results from different studies [24, 253]. The cytotoxic events of 
antibodies and complement begin only if complement components pass through the 
membrane. Binding of the first complement component (C1q) to IgM or IgG initiates 
a cascade ending in cell lysis. However, IgM (750 kDa) and C1q (400 kDa) are larger 
than IgG (150 kDa). Thus, it has been suggested that if passage of IgM and C1q 
across the barrier is prevented, a specific antibody-mediated attack on the islet cells 
should be prevented [21]. Numerous studies indicate that prevention of host-donor 
cell contact may be enough to hinder the activation of the cellular responses. Lanza 
and coworkers showed that Ca-alginate gel beads permeable to IgG and complement 
protected islet xenografts against destruction in mice [266] and more recently Dufrane 
et al [201] showed that xenografts in non-human primates were partly protected in 
spite of the ingress of both IgG and IgM. In general, encapsulation of xenograft will 
require more stringent permeability control as the host response to xenogeneic tissue 
will be stronger than to allogeneic tissue where the shed antigens in the former case 
quickly will be recognized as foreign [26, 212]. Finally, the transplanted cells may 
need to be protected against antibodies produced during the preexisting autoimmune 
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disease, in case of Type 1 diabetes, which might bind to surface antigens on 
transplanted cells [21]. 
 
In Paper 2 we showed that Ba-alginate beads were on the limit of excluding IgG, 
although confocal images of fluorescence labeled IgG revealed that IgG was able to 
diffuse into the bead center. Results from Paper 3 pointed to a reduction in 
permeability of Ca-alginate gel beads by increasing the amount of alternating 
structure in the alginate backbone using the C-5 epimerase AlgE4, and in Paper 5 the 
permeability was further reduced by making novel alginate materials with G-blocks 
intersperced by long alternating sequences using a combination of epimerases. In all 
these cases, the reduced permeability compared to controls (Ca-alginate gel beads) 
can probably be attributed to the increased stability preventing the swelling of beads 
which would lead to increased porosity. For epimerized samples the high degree of 
syneresis, particularly profound for samples in Paper 5, likely led to further reduction 
in permeability due to the more compact gel network. Lastly, in Paper 1 and 5 the 
inhomogeneous polymer distribution in beads of Ba-alginate and epimerized alginate, 
respectively, might have contributed further to lowering the porosity for these gels.  
 
Control of pore sizes in the tens of nanometers has been suggested as the most 
realistic way to achieve immunoisolation [38, 280]. In one study pore size of 18 nm 
and lower was shown to be required to keep IgG out of a semi-permeable membrane 
[189]. However, choosing the “ideal” pore size will always be a compromise. Keeping 
out TNF-α (51 kDa) may for instance also prevent the ingress of the iron-transporting 
protein transferrin (80 kDa), important for cell function [265] whereas protecting cells 
from the detrimental effects of IL-1β [281] may be difficult without concomitantly 
hampering the egress of insulin (see Figure 13).   
 
4.3.2 Biocompatibility 
A host response to capsules has been shown to start immediately after implantation, 
initiated by the inflammation caused by the implantation of the capsules. Since this is 
difficult to avoid, especially without the use of immunosuppressives, it is apparent 
that that manipulation of the capsule properties in order to reduce host reactions 
would be a favorable course of action [212]. In recent years the method of using 
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simple Ba-alginate beads in order to avoid the polycation layer, has been exploited by 
many researchers giving promising results both in allo- and xenograft transplantation 
[174-176, 205, 206, 236, 282-285] as well as in biocompatibility studies on empty 
beads [236]. In Paper 2 we demonstrated the increased stability and decreased 
permeability for Ba-alginate gels, factors which might contribute to the high success 
rate of this system. In addition to this, the observed binding of Ba2+ ions to 
mannuronic acid residues (Paper 2) may be a positive contributor to the 
biocompatibility of Ba-alginate beads. The binding of barium, although weak, might 
prevent low MW alginate oligomers enriched in mannuronic acid to leak out of the 
beads evoking an immune response [140]. Moreover, this may be completely avoided 
by using a two-step epimerization of mannuronan in which the product contains MG 
and GG blocks solely (Paper 5).  
The feasibility of manipulating specific capsule properties using mannuronan C-5 
epimerases was demonstrated in present work (Paper 3, 5 and 6), possibly bringing us 
one step closer to making a biocompatible alginate bead with improved functionality. 
However, the functionality and biocompatibility of these beads with islets in vivo still 
remains to be studied. So far, no differences in biocompatibility were found 
comparing empty Ca/Ba alginate beads of epimerized and non-epimerized high-G 
seaweed alginate [216].  
While several factors, some of which are not identified [239], are likely to influence 
biocompatibility, numerous studies have demonstrated that achieving a suitable level 
of biocompatibility requires, at minimum, a highly purified alginate [239, 286, 287]. 
The main factor hampering the use of the novel epimerized materials in vivo has so far 
been their high content of proteins (epimerases) and LPS, the latter stemming from 
the bacterial production of both the mannuronan alginate and epimerases (section 
1.4.2). The production of epimerases in GRASi organisms is currently being tested, 
allowing for endotoxin free alginate products. 
Although sample purity has been acknowledged as an important factor in 
biocompatibility issues, having viable cells inside the capsule might be of equal 
importance. Damaged or hypoxic islets may produce stress proteins [212], and 
components of dying cells may leak out of the capsule causing an immune response. 
In addition, as topography has shown to have impact on biocompatibility [40, 250], 
                                                 
i Generally Recognized As Safe 
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the surface roughness of alginate beads as compared to capsules might need to be 
evaluated [40].  
Enhanced biocompatibility of alginate/polycation microcapsules can also be achieved 
by reducing the amount of polycation bound and/or increasing the binding of the outer 
alginate coating for a more efficient shielding of the positive charges [216, 241]. The 
implications of the results in Paper 3 are that using a core of alginate epimerized with 
AlgE4 produces a more stable and less porous capsule than using the native alginate. 
Because the increase in alternating sequence stabilizes the gel, lower amount of 
polycation is required to produce small and stable capsules, at the same time retaining 
the porosity characteristics with regard to ingress of IgG and TNF. Also, using an 
epimerized alginate with polyalternating structure as coating material is believed to 
increase the biocompatibility due to better coating of the toxic polycation layer [216].  
 
It may be that ultimately the simplest system of them all, the alginate bead, will be 
sufficient to provide immune protection in the case of allogeneic models, whereas the 
development of microcapsule materials for xenogeneic models will remain a 
challenge. In this respect, results from the present work have given more insight into 
the possibilities for improving the stability and permeability characteristics of gel 
beads.  
So far, the major pitfalls making it difficult to interpret whether the alginate gel beads 
will be suited for islet transplantation have been the large discrepancies in results from 
animal studies from the various groups working with alginate encapsulated islets. A 
system working in one animal model may not work in another slightly different 
model, depending on the capsule properties, animal model and transplantation site. In 
general, the lack of standardization between laboratories has been a major contributor 
to this. Ongoing preclinical trials in non-human primates, and pending clinical trials in 
humans on Ca/Ba alginate beads containing human islets [288], will hopefully 
provide better understanding on this topic in the near future. 
 
Table 2 summarizes the major advantages and disadvantages of using alginate gel 
beads as an immunoprotective membrane for cell transplantation. 
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Table 2. Advantages (+) and disadvantages (÷) for using alginate gel beads as compared to 
alginate-polycation capsules for immunoisolation. 
+ ÷ 
• Increased biocompatibility • Lower stability 
• More open network - allows easier  
diffusion of nutrients and cell products 
which may be hampered by the 
polycation layer [265, 289] 
• Larger porosity – allows easier access 
for immune components   
• Non-toxic   
• One-step process – mild conditions for 
cells and easier to produce 
 
• Protrution of cells less likely to occur 
[290]  
 
 
• Negative surface charges - may exclude 
immune cells [278] 
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5 CONCLUDING REMARKS 
In spite of extensive research in the field of immunoisolation over the recent years, 
optimization of alginate capsules is still needed for them to become useful in the 
clinic as an immobilization device. The present work aimed at optimizing the alginate 
encapsulation system for cell therapy purposes, with particular focus on the treatment 
of Type 1 diabetes.  
In this respect, we have shown that added knowledge about the alginate structure-
function relationships is of great importance, as careful selection and manipulation of 
both capsule materials and encapsulation procedures made it possible to improve the 
functional properties of alginate microcapsules.  
 
In particular it was demonstrated that: 
 
• The encapsulation procedure influenced the final capsule structure and properties, 
and that CLSM proved to be a convenient tool to study the effect of different 
factors during capsule formation as well as the final characterization of alginate 
microcapsules. 
 
• A proper combination of gelling ion and alginate material was of great importance 
in order to improve and control the functional properties of alginate gel beads.  
Large differences were seen on the selection of type of gelling ions on both the 
swelling properties and gel strength of high-G alginate and high-M alginate. 
 
• Increasing the amount of alternating structure in seaweed alginates enhanced the 
functional properties of alginate beads and capsules with regard to stability and 
permeability.   
 
• G blocks in fact are not the only sequences involved in junction formation, but that 
long alternating sequences also play an important part in the in the alginate gel 
network by forming MG-MG and mixed MG-GG junctions. 
 
• Utilization of specific epimerases made possible the modification of polymer 
nanostructure, resulting in completely new alginate materials with highly 
improved functional properties.  
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